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«Alla fine sono arrivata a credere in una ricerca che io chiamo “La 
Fisica dell’Anima”, una forza della natura governata da leggi reali 
quanto la legge di gravità. La regola di questo principio funziona 
più o meno così: se sei abbastanza coraggiosa da lasciarti indietro 
tutto ciò che ti è familiare e confortevole e che può essere 
qualunque cosa, dalla tua casa a vecchi rancori, e partire per un 
viaggio alla ricerca della verità, sia esterna che interna, se sei 
veramente intenzionata a considerare tutto quello che ti capita 
durante questo viaggio come un indizio, se accetti tutti quelli che 
incontri strada facendo come insegnanti, e se sei preparata 
soprattutto ad affrontare e perdonare alcune realtà di te stessa 
veramente scomode, allora la verità non ti sarà preclusa.» 
Eat, Pray, Love  
E. Gilbert
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1 Introduction  
 
1.1 The RE1-Silencing Transcription Factor (REST)  
 
The acquisition of our identity depends on extrinsic and intrinsic factors that, if harmoniously 
orchestrated, allow us to BE our proper phenotype. Likewise, neuronal maturation occurs through 
an intricate network of signalling molecules and epigenetic modifications that leads to the 
acquisition and maintenance of neuronal identity. 
A key actor in this regulation process is the repressor element 1 (RE1)-silencing 
transcription factor (REST), also known as Neuron-Restrictive Silencer Factor (NRSF), and its co-
repressors that play a particularly important role in neuronal maturation and function. REST is a 
member of the Kruppel-type zinc finger transcription factor family. It represses transcription by 
binding a DNA sequence of 21–23 bp, called neuron-restrictive silencer element (NRSE, also 
known as RE1)[1, 2]. REST was discovered in 1995. Originally believed to silence neuronal gene 
expression in non-neuronal cells, several works revealed its diverse functions as a transcriptional 
and epigenetic regulator, whose function is highly context-dependent in neural and non-neural cells, 
where it can act as both silent repressor and active protector [3]. 
The human REST gene spans 24 kb of genomic DNA, which are transcribed into a full-
length messenger RNA of 1097 amino acids, encoding a glycoprotein of 210 kDa. REST harbors 
three functional domains: a DNA binding domain containing nine zinc-finger motifs that bind to the 
RE1 motif, and two independent repressor domains. The repressor domain at the amino terminal 
interacts with mSin3, a corepressor that recruits histone deacetylases (HDAC-1, -2), while the 
domain at the carboxy-terminal interacts with the CoREST complex, which contains HDAC1/2, the 
ATP-dependent chromatin-remodelling enzyme BRG1, the H3K4 demethylase LSD1 and the H3K9 
methylase G9a. The recruitment of REST and its associated corepressors onto target genes leads to 
the removal of several modifications that are associated with active gene transcription, thus altering 
the chromatin landscape to achieve gene silencing (Fig. 1.1) [4]. 
REST mRNA is composed of three alternative 5' non-coding exons associated with different 
promoters, three coding exons and an internal alternative exon that is spliced into some neuron- and 
disease-associated transcripts. Five splice variants of REST have been identified [5], four of which 
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(REST1, sNRSF, REST-N62 and REST4) encode for truncated proteins, whereas REST5 lacks the 
second exon. REST4 retains the N-terminal repressor domain and five of the nine DNA-binding 
zinc fingers. This neuron specific isoform is conserved in human, mouse and rat [6] and is formed 
by an insertion of 16 nucleotides, followed by an in-frame stop codon, regulated during alternative 
splicing by neural-specific Ser/Arg repeat-related protein of 100 kDa (nSR100/SRRM4). Thus 
REST4 itself does not bind to RE1 sites but has a dominant negative function by inhibiting the 
REST-DNA contact [7, 8]. Conversely, REST directly represses nSR100 in non-neural cells to 
prevent the activation of neural-specific splicing events. 
 
 
Figure 1.1. Representation of REST and associated corepressors when bound on a target sequence. 
The initial step in REST-mediated gene repression is the recruitment of the mSin3a and CoREST co-
repressors to the RE1 cis-sites on target gene promoters. mSin3a and CoREST in turn recruit the chromatin-
remodelling enzymes HDAC1, HDAC2, G9a and LSD1. The REST-DNA interaction is stabilized by the 
ATP-dependent enzyme BRG1. When bound to chromatin, the BRG1 complex repositions nucleosomes with 
respect to DNA, presumably allowing REST to form a more stable interaction with the DNA. The REST 
complex creates a negative chromatin landscape, thus preventing gene transcription. Image taken from 
Hermanson [9] 
 
1.1.1 REST: a neuroepigenetic factor 
 
Nervous system development requires the expression of negative and positive factors that regulate 
the precise spatial and temporal acquisition of the different neural lineages. This orderly acquisition 
of the various neural fates is mediated by specific networks of transcriptional activators and 
repressors in response to environmental and intrinsic cues. A number of studies have demonstrated 
that REST is a key determinant of neuron-specific gene expression, and an important regulator of 
neuronal gene expression during early embryogenesis. Indeed the full deletion of REST in mice is 
lethal at embryonic day 11.5 [10]. REST knockout (KO) embryos develop normally until 
embryonic day 9.5, after which they undergo massive apoptotic cell death that results in 
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malformations of the developing nervous system and insufficient growth. Interestingly, the absence 
of REST per se does not activate REST target genes, indicating that the expression of neuronal 
differentiation genes requires both the absence of REST and the presence of other tissue-specific 
positive transcription factors [10]. REST is predicted to repress more than 2000 neuron-specific 
genes, including genes encoding synaptic vesicle proteins, ion channels, neurotransmitter receptors, 
and miRNAs, which have been analyzed in non-neuronal tissues and undifferentiated neural 
precursors [3, 11, 12]. Its expression decreases during neuronal development allowing the correct 
differentiation of neurons. 
Recent works have revealed different mechanisms through which REST orchestrates the 
epigenetic regulation of target genes, suggesting that it can also activate gene transcription [13]. For 
example, REST binds the short form of TET3, guiding it to the promoters of RE1-containing genes. 
TET3 is the major methylcytosine dioxygenase expressed in neurons, which catalyses the 
conversion of 5 methylcytosine to 5 hydroxymethylcytosine. This modification is labile and can 
rapidly regenerate unmethylated cytosines, which in turn promote gene activation [14]. In addition, 
the REST-TET3 complex interacts with the histone-lysine N methyltransferease and two other 
H3K36 methyltransferases, to add a trimethylation moiety to the core histone protein H3, thus 
generating H3K36me3, which is a strong mark of gene activation [14]. REST cooperates also with 
other remodelling epigenetic factors, such as the methyltransferase enhancer of Zeste homologue 
(EZH2), the catalytically active component of Polycomb repressor complex 2 (PRC2), which act 
synergistically to silence target genes with REST [15]. Altogether, these observations reveal that the 
mechanisms by which REST controls the expression of neuronal genes are more complex than 
initially appreciated. 
1.1.2 REST in diseases 
 
The control of REST levels is so important that its dysregulation, both increment or decrement, 
gives rise to several neuropathologies. In brain, high REST expression levels have been associated 
to medulloblastoma and glioblastoma tumors [16, 17]. REST knockdown in human 
medulloblastoma cells abrogated their tumorigenic potential in mouse orthotopic models, whereas 
its constitutive expression in Myc-immortalized neural progenitors promoted tumor formation in 
vivo. REST levels are also related to the overall survival rate in patients affected by 
medulloblastoma, indeed patients with high REST levels have the worst overall survival compared 
with patients with REST-negative or low expressing tumors [18, 19]. REST is involved in the 
pathology of human glioblastoma multiforme (GBM), as it regulates the self-renewal, survival and 
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differentiation of malignant GBM cells. Thus, REST-regulated molecular circuitries may represent 
sensible targets for therapeutic intervention in GBM [17]. 
Epileptic seizures and ischemia are also associated to an increase of REST levels [20, 21]. In 
rats, ischemia induces an increase in REST expression in the CA1 region of the hippocampus, 
repressing the transcription of the μ-opioid receptor 1 (Opmr1) gene in inhibitory interneurons [22]. 
Inhibition of Opmr1 in turn induces an increased release of γ-aminobutyric acid (GABA), which 
lowers neuronal activity and probably has a neuro-protective effect [22]. REST plays also a role in 
downregulation of 4 aminopyridine (4AP)-induced neuronal hyperexcitability, re-establishing a 
physiological spiking activity in the neuronal network. As shown in the work of Pozzi et al, the 
long-term treatment of neural cultures with 4AP enhances the expression of REST, which results in 
down-regulation of Nav1.2 channels, thus decreasing the neuronal Na
+
 current density. This work 
showed that REST is involved in the molecular mechanisms driving the homeostatic response 
induced by neuronal hyperactivity [23]. Quite a different result was obtained in the 
pentylenetetrazol (PTZ) model of acute seizures, using animals in which the conditional deletion of 
REST was achieved through mating with mice expressing the Cre recombinase under the neuron-
specific enolase (NSE) promoter, which ablates the REST gene from most if not all neurons. 
Although the initial clonic convulsions caused by PTZ were not different between REST cKO and 
control mice, tonic convulsions and death required a higher PTZ dose [24] These findings would 
suggest that REST might contribute to seizure initiation or generalization. Therefore the role of 
REST in epigenetic mechanisms related to epilepsy is still debated. 
Recently, a new role of REST as protective factor in neurodegenerative diseases has been 
unveiled. In the work of Lu et al, the role of REST in stress resistance, ageing and Alzheimer’s 
disease (AD) has been investigated. The authors measured the protein and mRNA levels of REST in 
the prefrontal cortex (PFC) of three groups of individuals: young adults (20-35), aged (73-106), and 
patients with AD. An increment of REST levels in the ageing human PFC was observed, compared 
to the young adult group, thus suggesting that REST expression is increased in ageing neurons. 
ChIP-seq analysis showed that REST represses genes involved in cell death, such as p38 MAP 
kinase, BAX, and PUMA, which are associated with AD and dementia. Reduced REST binding to 
these genes, and a consequent higher mRNA expression, were characteristic features of AD brains. 
Because of the observed REST-mediated repression of pro-apoptotic genes, in order to assess the 
role of REST in neuroprotection, REST deficient neurons were treated with hydrogen peroxide and 
their vulnerability to oxidative stress was assessed. REST-deficient neurons showed a markedly 
increased degeneration and cell death compared to controls, consistent with a neuroprotective role 
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of REST [25]. REST activity has been also implicated in the pathogenesis of Huntington’s disease 
(HD). Wild-type huntingtin binds REST, sequestering it in the cytosolic department, while the 
mutated, pathogenic form loses the ability to bind REST thus causing its accumulation in the cell 
nuclei. This causes the consequent reduction of the transcription of REST-dependent neuronal 
genes including BDNF, which is a fundamental trophic factor required for the correct activity of 
cortico-striatal synapses and for the survival of the GABAergic medium-sized spiny striatal neurons 
that die in HD [26, 27]. 
The neuroprotective role of REST has been explored also in the pathogenesis of prion 
disease. In the work of Song et al, the authors treated primary cultured cortical neurons with the 
neurotoxic prion protein fragment 106-126 (PrP106-126), a widely used model for the in vitro study 
of prion-associated pathological damage. REST protein expression was examined at various time 
points (up to 48 h) by immunofluorescence and western blot analysis after 24 h of treatment with 
PrP106-126. REST expression was 1.6 to 1.9 fold higher than in non treated samples between 6 and 
24 h. Thereafter, its expression gradually declined reaching control levels at 48 h, which was 
probably due to proteasomal degradation. The nucleo-cytoplasmic shuttling of REST was also 
analysed, revealing decreased protein levels in the cytoplasm and a corresponding increase in the 
nucleus, compared with the untreated control group. In addition, overexpression of REST rescues 
the physiological alterations induced by PrP106-126, decreasing apoptosis by stabilizing the level 
of the pro-survival protein FOX1. The authors also explored the relationship between REST and 
LRP6, a key component of the LRP5/LRP6/Frizzled co-receptor group that is involved in the 
canonical Wnt pathway. They observed that the activation of Wnt-β-catenin signaling induced by 
LRP6 receptor after stress stimulus in turn activates transiently REST and β-catenin, suggesting a 
critical role of REST and Wnt-β-catenin signalling in maintaining cellular integrity and protecting 
neurons from death [28]. 
REST is also significantly depleted in frontotemporal dementia and dementia with Lewi 
bodies. In samples from patients affected by these pathologies, REST is lost from the nucleus and it 
appears in authophagosomes with pathological misfolded proteins, including A, phosphorylated 
tau and alpha synuclein, suggesting that epigenetic regulation of chromatin may modulate the 
cognitive outcome of a variety of pathologic states [25]. 
In non-neural cells, including epithelia, REST expression is high and plays the role of tumor 
suppressor. Indeed, reducing REST function through RNAi or expression of dominant-negative 
REST peptides, promotes transformation of human epithelial cells. Conversely, reconstitution of 
REST expression elicits a dramatic proliferation defect in colon cancer cells that have lost 
endogenous REST function [29, 30]. More evidence in support to the tumor suppressor role of 
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REST comes from works demonstrating that REST expression was absent in a subset of small cell 
lung cancers, and in prostate cancer [31, 32]. 
 
1.1.3 REST and REST-dependent pathways as targets of molecular 
therapy 
 
Given the relevance of REST dysregulation in a number of neuronal pathologies, various molecular 
strategies have been developed to modulate its action. In order to decrease the activity of REST in 
Huntington disease, a oligonucleotide (ODN)-based approach has been used, consisting in a 
short double-stranded-DNA that mimics the RE1 cis-site to sequester REST and reduce its 
activity. Despite the promising results, the ODN decoy strategy faces great challenges when 
target gene expression has to be inhibited in vivo only in a single organ or tissue type. In fact, 
systemic delivery of ODNs may result in a widespread uptake and potential nonspecific side 
effects. Moreover, a successful use of ODN decoys depends on the efficient delivery of the 
synthetic DNA to target cells [33]. The reduction of REST activity in vivo has been achieved 
through the use of adeno-associated viral vectors (AAVs) expressing a dominant negative 
REST protein (DN:REST). Such protein comprised only the Zn finger domain region, without 
the N- and C-terminus, and was able to compete with the wild-type protein for the binding to 
target promoters, thus maintaining an open chromatin conformation [34]. However, the main 
drawback of this approach is that the long-term expression of DN:REST driven by the AAV 
promoter produced excessive levels of the protein. To achieve a more selective competition of 
REST a small peptide that blocks the mSin3-REST interaction has been used, which inhibited 
the formation of the multi- protein complex on gene promoters. This approach is promising, 
however small peptides still present major challenges in vivo, such as limited tissue penetration 
and possible immune reaction that can cause toxicity and neutralize their therapeutic activity  
[35]. 
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1.2 Light-sensitive Proteins and Optogenetics 
 
Optogenetic techniques recently emerged as a powerful and promising tool, particularly in the 
field of neuroscience. The optogenetic approach is based on the artificial introduction of 
photo-sensitive proteins into or on the surface of a target cell, with the aim of making specific 
cellular processes light-sensitive. The earliest photoactivatable systems were light-controlled 
caged molecules, such as neurotransmitters and ion channels [36]. The first optogenetic tool 
used in primary neurons was channelrhodopsin2 (ChR2), which enables the light-driven 
depolarization of neuronal membranes, and halorhodopsin (NpHR), [37-39] which induces the 
light-tunable hyperpolarization of membranes to inhibit action potential. These molecules are 
still widely employed, but have been flanked by new and more refined optogenetic tools, 
which provide a more robust and precise cell manipulation, enabling more complex 
experimental designs. Another interesting class of optogenetic protein is represented by 
OptoXRs opsin–receptor chimaeras in which the intracellular loops of rhodopsin were replaced 
with the intracellular loops from other G protein-coupled receptors (such as adrenergic 
receptors) to obtain a light-induced activation of specific G protein-coupled signalling 
pathways in targeted neurons in vitro and in freely moving mammals. The use of OptoXRs 
allows to alter excitability in a given neuronal population on a longer time scale, bypassing the 
need to continuously evoke action potential firing (Fig. 1.2). 
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Figure1.2. Membrane-associated optogenetic tools. Optogenetic molecules include cation permeable 
channels for membrane depolarization (channelrhodopsin, ChR), chloride pumps (halorhodopsin, NpHR) 
and proton pumps (bacteriorhodopsin or proteorhodopsin (BR/PR)) for membrane hyperpolarization. The 
light-activated membrane-bound G protein-coupled (OptoXR) or soluble (bacterial cyclase) receptors can be 
employed to trigger the activation of various signalling cascades. Taken from Tye et al [40]. 
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Besides the described membrane-associated proteins, other classes of intracellular optogenetic 
molecules are used. These proteins mainly belong to three categories, i.e. phytochromes, 
cryptochromes and light-oxygen voltage domains (detailed in the next section). Phytochromes are 
expressed in plants and cyanobacteria and contain a chromophore that consists of a covalently 
linked tetrapyrrole, Upon red light exposure, the isomerization of the tetrapyrrole cofactor 
induces a conformational change of the protein structure, which switches from a red-absorbing 
(Pr) to a far-red-absorbing (Pfr) state. In the dark, the Pfr state spontaneously reverts to the Pr 
state with slow kinetics, alternatively, a far-red light stimulus can induce a quicker 
conversion.[41] (Fig. 1.3a). Cryptochromes are flavin adenine dinucleotide (FAD)-binding 
proteins that regulate growth in plants and circadian clocks in animals. In plants, blue light 
induces FAD reduction and a consequent conformational change in the cryptochromes, which 
spontaneously reverses in the dark. In cryptochrome 2 (CRY2) of A. thaliana, the light-
induced conformational change facilitates the interaction with the calcium and integrin -binding 
protein 1 (CIB1). This event has been used by Kennedy et al. to recruit proteins to the cell 
membrane or to induce the binding between a transcriptional activation domain and a DNA-binding 
domain [42](Fig. 1.3b). 
  
Figure 1.3. Intracellular optogenetic tools. a. Phytocrome-based strategy. Upon red light absorption, Pr 
interacts with a target domain, inducing the activation of the fused proteins, Pr, red light-absorbing molecule; 
Pfr, far red light absorbing molecule. b. Examples of cryptochrome-associated strategies. CRY2-CIB1 
interaction recruits a selected protein to cell membrane. 
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1.3 Light Oxygen Voltage (LOV) Domains 
 
Light, oxygen, or voltage (LOV) domains were first identified as protein sensors involved in 
blue-light absorption in plants. Phototropins LOV domains are included in key photoreceptor 
kinases that modulate light-dependent processes such as phototropism, light-directed 
chloroplast movement and signalling processes across all life kingdoms, particularly in plants, 
fungi and bacteria [43, 44]. Structurally, LOV domains belong to the large and versatile Per-
ARNT-Sim (PAS) domain superfamily. Their molecular conformation reflects the canonical 
PAS domain fold, with a central structure containing a five-stranded antiparallel β sheet and 
several α helices (Fig. 1.4a). The inner portion of this α/β core is non-covalently associated to 
the flavin mononucleotide (FMN) cofactor, the principal form of riboflavin found in cells and 
tissues. The small FMN cofactor absorbs blue light with a maximum peak ranging from 450 to 
470 nm. Upon photon absorption, FMN enters in a photo-excited state enabling the formation 
of a covalent thioether adduct between the 4a carbon (C4a) of its isoalloxazine ring and a 
conserved cysteine residue (C450) within the LOV domain [45] (Fig. 1.4b). On the 
microsecond time scale, this induces a larger conformational rearrangement of the inner β 
sheet, which propagates to the outer structures. The external portion of the LOV domain is 
formed by one amino- and one carboxy-terminal α helix, termed A′α and Jα, respectively [46, 
47], which are associated to the central sheet, opposite to the FMN-binding pocket. Following 
the photo-induced structural changes, both terminal α helices are displaced and  unfolded. 
Giving that the carboxy-terminal Jα helix function as an interaction hub, as in other PAS 
domains, the rearrangement of this region mediates signal transduction to the effector domains.  
LOV domain-containing proteins can be subdivided into five functional categories, 
depending on their function: phototropins, proteins regulating circadian rhythms, LOV histidine 
kinases, LOV-STAS proteins, and LOV phosphodiesterases. Amongst the various LOV-containing 
proteins, phototropins are particularly interesting as they contain two LOV domains (LOV1 and 
LOV2) instead of a single LOV sequence. LOV2 exhibits a higher efficiency of the light-dependent 
switching and a slower rate of dark recovery, compared to LOV1. Considering the properties 
described, the phototropin LOV2 domain has been preferentially used in the design and 
construction of engineered photoreceptors. In this context, the Avena sativa LOV2 (AsLOV2) 
domain has been widely employed. Strickland et al. [48] created a chimeric protein fusing the 
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AsLov2 Jα helix to the N-terminus of the Trp repressor protein (TrpR) obtaining a longer shared 
linking helix (Fig. 1.4c). The resulting fusion protein, named LOV-TAP, displayed light-regulated 
activity, showing a weak DNA affinity in the dark state and a ~5-fold higher affinity upon 
illumination. In this model, the shared linker helix was folded against the LOV core in the dark 
obstructing the TrpR domain, while upon blue-light stimulus the linker helix relaxed, thus restoring 
the structure and function of TrpR. With a different approach, Wu et al. used the AsLOV2 domain 
to modulate the activity of the small GTPase Rac1 [49]. The rationale underlying this strategy was 
to block the active site of Rac1 in a light-dependent manner. In the chimeric protein, named PA-
Rac1, LOV2 was fused via its C-terminal Jα helix to the N-terminus of Rac1 with the intent to 
obstruct the active site in the dark (Fig. 1.4c). Following blue-light irradiation, the Jα helix 
unfolded, releasing the Rac1 domain and exposing its active site. The open PA-Rac1 was able to 
bind its downstream effector protein PAK with approximately the same affinity as wild-type Rac1, 
whereas in the dark the affinity was 10-fold lower. Moreover, the expression of PA-Rac1 allowed to 
control the motility of cultured fibroblasts when the appropriate light stimulus was provided. In 
conclusion LOV photosensor domains, and particularly the AsLOV2 domain, can efficiently be 
coupled to effector proteins by domain fusion to obtain light-induced changes in the biological 
activity of cells and organisms. 
 
Figure 1.4. Light, oxygen, voltage (LOV) domain and some of its applications. a. AsLOV2 is folded in 
the canonical PAS conformation and binds FMN. Blue-light absorption induces the formation of a covalent 
bond between the flavin ring and the conserved cysteine residue C450 (red arrow). Light signals are 
propagated to and through the β sheet (green arrow). Here, they promote unfolding of the C-terminal Jα helix 
(in green; blue arrow). b. The LOV photocycle depends on the blue-light induced formation of a thioether 
bond between C450 residue and atom C(4a) of the flavin cofactor. The lit state reverts thermally to the 
ground state (adapted from Moglich et al) [41]. c. In LOV-TAP, the Trp repressor has a weak affinity for 
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DNA in the dark, whereas the DNA binding domain is exposed upon illumination, thus promoting Trp-DNA 
binding. In PA-Rac, the enzyme Rac1 is fused to the C-terminus of AsLOV2. Upon blue light stimulus, the 
Jα helix unfolds allowing the interaction between Rac1 and PAK1 (adapted from Hahn KM et al) [50]
13 
 
 
1.4 Target RNA to Play with Cells! 
 
RNA molecules play an active role within cells by catalyzing a number of fundamental biological 
reactions. RNA controls the expression of the encoded protein by providing a template for 
translation, and regulates translation through alternative splicing or RNA editing. Several types of 
non coding RNA (ncRNA), such as micro- or short interfering RNAs (miRNA, siRNA) can 
downregulate gene expression through specific association to a complementary mRNA sequence 
[51, 52]. Moreover localization of mRNAs to specific destinations within a cell or an embryo is 
important for local control of protein expression. Thus, because of the high number of processes in 
which RNA is involved, it represents an optimal candidate to manipulate these functions in living 
cells. Many progresses have been made in designing DNA binding proteins able to activate, silence 
or modify double-stranded DNA with chosen specificity [53]. Promising systems for DNA 
manipulation are now available such as Zinc Finger (ZF) domains, the transcription activator-like 
effector (TALE), and the guide RNA-based CRISPR-associated (CAS9) system, a powerful tool in 
the field of genome editing and recently also in RNA knowdown [54]. However equivalent 
programmable RNA binding modules to enable manipulation of a specific RNA are not widely used 
[55]. 
The most common approach to manipulate RNA is through RNA interference (RNAi), 
which uses sequence-specific siRNAs, synthetic miRNA and miRNA inhibitors that regulate 
transcriptional or post-transcriptional gene silencing [56]. However the RNAi technology has some 
limitations, such as the instability of siRNAs, their off target effects and the immune response 
elicited by their injection in vivo. Thus, the development of tools able to safely edit RNA with 
minimal side effects is highly needed and desirable. 
 
14 
 
 
1.4.1 RNA binding proteins 
 
RNA-binding proteins (RBPs) play an essential role in every aspects of RNA biology. Their 
dynamic association with RNA determines the cellular localization, lifetime, processing and 
translational rate of coding and non-coding RNAs. In the last two decades researchers have focused 
on understanding the structural basis for RNA recognition, in the interest of designing RNA-
binding proteins with tailored sequence specificity for therapeutic applications. It is now established 
that RBPs are composed of modular repeats of just few domains that, combined in various 
arrangements, can generate versatile recombinant proteins capable to bind RNA with higher affinity 
and specificity than the individual domains [52]. 
Several efforts have been made to alter gene expression by targeting RNA through RNA-
binding proteins. The most known and used RBDs are the spliceosomal protein U1A, the MS2 coat 
protein that link proteins to RNA with the purpose of tracking mRNA localization, and the iron 
responsive element (IRE) RNA-binding protein IRP-1 fused with the C-terminal region of the 
eIF4G human translation initiation factor, used to drive translation of reporter genes. However all 
these RBPs require the insertion of the protein-binding sequences into the target RNAs, since they 
are unable to operate on endogenous mRNAs, thus requiring the engineering of an artificial reporter 
bearing the specific recognition site. The RNA Recognition Motifs (RRMs) have a size of 80-90 
amino acids and are characterized by α helices packed against a four stranded anti parallel β-sheet. 
The centre of the β-sheet allows the recognition of two nucleotides on one side and of two 
additional nucleotides on the other side. This conserved platform is not sufficient for sequence 
specificity and many dynucleotide combinations are recognized by this motif; moreover the 
topology of the bound RNA varies in each complex, depending on its secondary structure. Because 
of all these reasons, it has been difficult to engineer RNA binding proteins using RRMs [57]. 
Another class of RNA binding domains is represented by repeats that generate extended 
structures with a large surface suitable for protein-protein and protein-RNA interactions. Many of 
these proteins have been identified, including Pumilio and FBF protein (PUF) (Fig. 1.5a, described 
in detail in the next section), pentatricopeptide repeats (PPR) and trp RNA-binding attenuation 
proteins. In all these proteins, each repeat interacts with one base in a modular fashion, thus 
dictating sequence specificity in a predictable manner (Fig. 1.5). PPRs, less characterized than PUF 
proteins, localize primarily in mitochondria and chloroplasts where they influence various aspects 
of RNA metabolism [58]. PPRs contain 2-30 tandem repeats each one composed by 35 amino acids 
forming a super-helical binding surface (Fig. 1.5b). The RNA is bound in an anti-parallel 
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orientation with respect to the PUF protein. Each motif binds one nucleic acid; the amino acid in 
charge of recognition is at position 6, distinguishing purines from pyrimidines. The next most 
important amino acid is at position 1, which distinguishes between C/A and G/U. The amino acid at 
position 3 may also affect binding and specificity directly or indirectly, providing hydrophobic 
interactions with the RNA bases. PPR proteins do not discriminate well between uridine and 
cytidine and because of this feature show some limitations in sequence specificity with appreciable 
off target effects. Another limitation is represented by the physiological localization of these 
proteins to organelles, and their widespread diffusion in plants and groups of protists and 
metazoans, which pose difficulties when transferring these tools into mammalian cells. 
 
  
 
Figure 1.5. Conformational structure of PUF and PPR protein with RNA. a. Crystal structure of PUM1 
(residues 996-1067; PDB ID 1M8W). The RNA base contacts residues 12 and 16 (magenta) in the PUF 
repeats. Residue 13 (cyan) stacks between adjacent nucleotides. b. Crystal structure of two PPR motifs from 
human mitochondrial RNaseP (residues 96-175; PDB ID 4G23). Amino acids that determine RNA binding 
specificity are shown in magenta and blue for repeat 1 (light gray ribbon) and repeat 2 (light brown ribbon), 
respectively. Adapted from Yagi et al [58]. 
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1.4.2 PUF proteins 
 
The PUF family of proteins is named after the founding members Pumilio in Drosophila 
melanogaster (DmPum) and fem-3mRNA-binding factor (FBF) in Caenorhabditis elegans. PUF 
homology proteins have been found in all eukaryotic organisms [59], where they regulate diverse 
processes including stem cell maintenance, organelle biogenesis, oogenesis, neuron function, and 
memory formation. At the molecular level, PUF proteins promote translational regulation of target 
mRNAs by first interacting with conserved cis-elements in the 3' untranslated region (UTR)[60]. 
PUF proteins are typically composed of 8 imperfectly repeated 36 amino acid motifs (PUF repeats) 
flanked by conserved sequences, which form a sequence-specific single-stranded (ss) RNA-binding 
domain. Each repeat is characterized by three helices that pack together to form a crescent-shaped 
right-handed super helix with a continuous hydrophobic core [61]. The RNA binds to the concave 
surface of the protein, where each repeat interacts with a single RNA base. The N-terminal repeat 
interacts with the 3’ end of the mRNA sequence, in an antiparallel configuration (Fig. 1.6). 
The crystal structure of a PUF domain from the human Pumilio 1 (HsPum1) protein in  
complex with RNA revealed its modular recognition code [62]. In each repetition, the amino acids 
at position 12 and 16 interact with the Watson-Crick edge of RNA bases, while amino acid at 
position 13 forms stacking interactions between aromatic rings of adjacent RNA bases. These three 
RNA-binding residues in HsPum1 are contained within a five-residue motif represented as (12-13-
X-X-16) (X being any hydrophobic residue). In this code, uracil is recognized by asparagine, 
glutamine and tyrosine; guanine by serine, glutamate and asparagine; adenine by cysteine, 
glutamine and arginine, and cytosine, identified by yeast three-hybrid selection [62], by serine, 
arginine and tyrosine (Fig. 1.6). 
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Figure 1.6. PUF protein and its modular recognition code used to engineered artificial PUFs. a. Left 
panel the crystal structure of HsPum1 binds to RNA in antiparallel manner by an arc-like shape disposal. 
Each repeats bind to single ribonucleotide following the recognition code reported in table (Right panel) In 
each repeat three RNA-binding residues, contained within a five-residue motif represented as (12-13-X-X-
16) (X being any hydrophobic residue), are involved in RNA base recognition. b. The code of PUF proteins 
allows to design artificial RNA binding proteins specific for a selected sequence. Rearranged from 
Filipovska et al [62] 
 
 
PUF proteins are versatile regulators, which employ multiple mechanisms to regulate their mRNA 
targets, repressing/ activating translation or contributing to mRNA localization [63]. Yeast PUF5 
acts as a post-transcriptional repressor recruiting the Ccr4-Pop2-NOT deadenylase complex on its 
specific recognition sequence in the 3’UTR of the target mRNA, shortening the poly(A) tail and 
consequently influencing both RNA stability and translation [64]. In addition to the deadenylase, 
the repressive complex recruited by PUF5 includes the decapping factors Dhh1 and Dcp1, which 
are associated with the Ccr4-Pop2-NOT complex and cause mRNA repression by affecting the 
hydrolysis of the 5’ cap. This mechanism of repression is conserved; however other repression 
mechanisms have also been investigated. For instance D. melanogaster PUM can recruit d4EHP on 
mRNA via its cofactor Brat, inhibiting translation by competing with the translational initiator 
factor eIF4E [65]. Two Pumilio proteins, Pum1 and Pum2, have been found in humans. They 
recruit Nanos, which is also involved in RNA localization, and Brat, which binds eIF4 inhibiting 
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transcription initiation. In addition, Pumilio has cap-binding activity itself and so it may compete 
with eIF4 to block initiation [66]. In some cases Pumilio could positively regulate mRNA stability 
and translation. In X. laevis cyclin B mRNA, PUM- and CPEB-binding sites cooperate to trigger 
translational activation, probably by stabilizing CPEB on the transcripts [67]. In C. elegans, PUF 
(named FBF) physically interacts with and activates the CCF-1/Pop2p deadenylase and also 
physically interacts with the GLD-2 poly(A) polymerase, enhancing its activity and ultimately 
affecting mRNA polyadenilation and translation in vitro [68]. One other mechanism of 
transcriptional activation is through competitive binding with repressor. Ribonucleoprotein-
immunoprecipitation microarrays and genome-wide analyis revealed that PUF motifs are enriched 
around predicted miRNA binding sites and that high-confidence miRNA binding sites are 
significantly enriched in the 3′UTRs of experimentally determined human PUM targets, strongly 
suggesting an interaction with the miRNA regulatory system [69]. Last but not least, experiments in 
yeast suggested an involvement of PUF proteins also in mRNA localization, indeed, PUF3 localizes 
mRNA to mitochondria, and PUF6 contributes to the asymmetric localization of ASH1 during 
transport to the yeast bud [70]. 
1.4.3 Applications of PUF proteins 
 
The elucidation of the RNA recognition code of PUF proteins allowed engineering of artificial 
RBPs for targeting endogenous mRNAs, permitting the manipulation of the transcriptome. These 
artificial constructs are composed of a RNA recognition module that binds a specific RNA target, 
and by a catalytic domain. Such constructs can be implemented in the regulation of a broad range of 
biological processes [71]. For instance, PUF constructs have been used for mRNA tracking and 
localization of endogenous mitochondrial RNA. Ozawa et al developed a tracking system to target 
mtRNA to the mitochondrial matrix; this system is composed by an enhanced GFP or Venus split in 
two parts, where each fragment is fused to a human PUMILIO1 specific for the NADH 
dehydrogenase subunit 6 (ND6) mtRNA. The addition of a mitochondrial targeting signal (MTS) to 
the PUF proteins allowed the correct localization to the mitochondrial matrix, permitting at the 
same time the real-time imaging of ND6 mtRNA (Fig. 1.7 a)[72]. One similar tool has been 
developed by Cooke et al to regulate translation in X. laevis oocytes through the stabilization of 
mRNA poly(A) tail. In this work, FBF-2 from C. elegans was fused to the poly(A) PAP polymerase 
GLD-2. The resulting fusion protein was able to guide polyadenylation of luciferase mRNA 
containing a specific FBF recognition site. In the same work FBF-2 was also fused to CAF1b, 
which could remove poly(A) from a radiolabeled RNA reporter (Fig. 1.7 b-c) [73]. In another study 
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the PUF domain was designed to target the 5’ UTR of mRNA and fused to the eukaryotic 
translation initiation factor 4E (eIF4E) to enhance translation of a reporter luciferase mRNA. The 
light-inducible heterodimerization of PUF and eIF4E through light-sensitive protein partners was 
also demonstrated, which allowed light-inducible translation activation [74]. In another approach 
the manipulation of mRNA splicing has been explored, whereby the PUF domain was used as a 
scaffold for engineering artificial splicing factors with designed sequence specificities and 
activities. These engineered splicing factors (ESFs) were constructed from a wild type or modified 
PUF domain of HsPUM1 fused to a glycine-rich domain of hnRNP A1 (Gly-PUF) or the arginine–
serine-rich domain of ASF/SF2 (RS-PUF). The designer ESF was able to shift the splicing of the 
endogenous pre-mRNA of Bcl-x towards the short Bcl-xS isoform, thereby promoting apoptosis, as 
well as promote splicing towards the anti-angiogenic isoform b of endogenous VEGFA gene in 
cultured cancer cells (Fig. 1.7 d-e) [75]. PUF-based fusion proteins with RNA cleavage activity 
have also been created in order to cleave (CUG)n repeats-containing transcripts in patient-derived 
DM1 (myotonic dystrophy type 1) cells. This recombinant protein could target the nuclear 
accumulation of the pathogenic RNA, thus rescuing the phenotype (Fig. 1.7 f) [76]. 
 
Figure 1.7. PUF applications. a. RNA tracking and localization using two PUF domains fused to a split 
Venus protein. b-c. PUF proteins engineered with a translational activator (GLD2) and a transcriptional 
repressor (CAF1) that regulate poly(A) tail length. d-e. PUF proteins able to influence alternative splicing. f. 
An RNA endonuclease fused to PUF. g. PUF designed to bind to the 5’ UTR region drives the initiation 
factor eIF4E on mRNA to activate translation. Taken from Abil et al [71]. 
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1.5 Aim of the study  
 
To interfere with REST dysregulation in neuronal pathologies, various molecular strategies have 
been developed with the purpose to restore the correct levels of expression of REST target genes. 
However, these approaches suffer from a number of limitations, including their transient activity, 
and the possibility to generate important side effects when used in long-term applications. In order 
to recover the expression of REST activity we choose two different approaches. In the first 
approach we decreased REST activity based on optogenetic tools able to interfere with the 
transcriptional factor in a spatiotemporal precise manner. We employed the A. sativa AsLOV2 
domain to engineer two recombinant proteins (AsLOV2-fused peptides) that can (i) prevent the 
interaction between REST and its cofactor mSin3a, or (ii) inhibit REST binding to target gene 
promoters decreasing indirectly REST activity in a light-sensitive way. 
In the second approach we attempted to increment REST expression, and explored the 
possibility to target directly its mRNA. We took advantage of the RNA binding proteins PUF, and 
engineered six PUF constructs designed to bind a specific sequence in the 3’ UTR region of murine 
REST mRNA. Three constructs are designed to recognize a specific eight-ribonucleotide sequence, 
and the other three are designed to bind to a sixteen-ribonucleotide sequence in the same region of 
the transcript. We verified the binding and the affinity of the six proteins for their target sequences, 
and identified two constructs with the highest affinity for endogenous REST mRNA. We confirmed 
our results through a molecular modelling analysis, in collaboration with Drs. Gatti and Maragliano 
(IIT-NSYN, Genova), who simulated the binding of our engineered proteins for their target RNA 
sequences. In addition we checked the function of our PUF constructs, demonstrating that they do 
not have any intrinsic effect on REST mRNA translational regulation. Thus, the PUF-based 
constructs described in this work are configured as excellent target-specific platforms. In the future 
they will be linked to functional proteins capable of modulating the stability of the REST transcript. 
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2 Materials and methods  
2.1 Materials 
 
All biochemical reagents and drugs were from Sigma-Aldrich (Milano, IT) and Promega (Milano, 
IT) unless otherwise specified. Tissue culture reagents and media were from Gibco (Life 
Technologies Corp, Monza, Italy) or Sigma-Aldrich. List of antibodies used: rabbit polyclonal anti-
GAPDH (#SAB3500247;Sigma-Aldrich), mouse monoclonal anti-His-tag (HIS.H8, #sc-57598; 
Santa Cruz Biotechnology D.B:A, Milano IT), rabbit polyclonal anti-GFP (#A-11122; Life 
Technologies), rabbit polyclonal anti-BDNF (H-117) (#sc-20981; Santa Cruz Biotechnology), 
rabbit monoclonal anti-FLAG (#F7425 Sigma), rabbit polyclonal anti-calnexin (#10286 Abcam, 
Milano, IT). Horseradish peroxidase (HRP)-conjugated secondary antibodies for western blot 
analysis were: stabilized goat anti-mouse IgG (H+L), peroxidase conjugated (#32430; Thermo 
Scientific, Monza, IT) and stabilized goat anti-rabbit IgG (H+L), peroxidase conjugated (#32460; 
Thermo Scientific). 
2.2 Mammalian Cell Culture and Light Stimulation 
Experiments 
 
Murine Neuro2a (N2a) neuroblastoma cells and human HEK293T cells were cultured in DMEM 
(#11965-092, Gibco) supplemented with 10% (vol/vol) FBS, glutamine (2 mM), and antibiotics, in 
a humidified 5% CO2 atmosphere at 37 °C. For light stimulation experiments, 750,000 cells were 
plated in 35 mm dishes, and the day after were transfected with 2.5 μg of the indicated vectors. 
Twenty-four hours after transfection, cells were subjected to light stimulation. Stimulation 
parameters were as follows: 0.34 mW/cm2, 470 nm, and 50% duty cycle (1-s light pulses) for the 
indicated time. After the stimulation period, RNA was extracted. For the control dark points, cells 
were maintained in the incubator wrapped in aluminum foil, to ensure complete dark conditions. 
Expression vectors were transiently transfected into cultured cells using Lipofectamine 2000 (Life 
Technologies) following standard procedures. 
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2.3 Protein Extraction and Western Blotting. 
Total protein lysates were obtained from cells lysed on ice for 20 min in RIPA buffer [20 mM 
Tris·HCl, pH 7.4; 1% Triton X-100; 10% (vol/vol) glycerol; 150 mM NaCl; 1% PMSF; protease 
inhibitor mixture: Complete protease inhibitor mixture tablets; #04693116001; Roche Applied 
Science (Monza, IT)]. The final protein concentration was quantified by using the BCA protein 
assay kit (#23225; Pierce Biotech, Monza, IT). Nuclear extracts were prepared as follows: the pellet 
from 5 × 10
6
 cells was resuspended in 400 μL cytoplasmic buffer (10 mM Hepes, pH 7.9, 1.5 mM 
MgCl2, 10 mM KCl, 0.5 mM DTT, protease inhibitor mixture) and incubated 20 min on ice with 
constant shaking. After the addition of 25 μL of 10% (vol/vol) IGEPAL, the solution was briefly 
vortexed and centrifuged 2 min at 8,000 × g at 4 °C. The supernatant containing the cytoplasmic 
extracts was collected, the pelleted nuclei were suspended in 50 μL nuclear buffer [20 mM Hepes, 
pH 7.9, 1.5 mM MgCl2, 420 mM NaCl, 0.2 mM EDTA, 25% (vol/vol) glycerol, protease inhibitor 
mixture] and incubated 20 min on ice with constant shaking. Nuclei were centrifuged 25 min at 
10,000 × g at 4 °C, and the supernatant (nuclear extract) was collected. The final protein 
concentration was quantified by using the Bradford protein assay (#23200; Pierce Biotech.). 
Proteins were separated using precast 10% NuPAGE Novex Bis-Tris Gels (Life Technologies) and 
transferred to a nitrocellulose membrane. After incubation with primary antibodies, membranes 
were incubated with HRP-conjugated secondary antibodies and revealed by autoradiography using 
the SuperSignal West Pico Chemiluminescent Substrate (#34077; Thermo Scientific). 
2.4 Immunofluorescence and Confocal Microscopy  
 
Cells were fixed with 4% (wt/vol) paraformaldehyde and 20% (wt/vol) sucrose in PBS for 15 min at 
room temperature (RT) and permeabilized with 0.1%. Triton X-100 in PBS for 5 min at RT. 
Samples were blocked for 30 min in immunofluorescence buffer [2% (wt/vol) BSA, 10% (vol/vol) 
goat serum in PBS]. Primary and secondary antibodies were diluted in immunofluorescence buffer 
and incubated for 45 min at RT. Coverslips were mounted using ProLong antifade (#P36931; Life 
Technologies) and imaged by confocal microscopy. Confocal fluorescent images were obtained 
using a Leica SP5 confocal microscope with a 40x and 20x objective and analyzed with the Leica 
LAS AF software. 
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2.5 RNA Preparation and qRT-PCR 
 
Total cellular RNA was extracted using RNeasy Mini Kit (#74104 Qiagen), and isolated RNA was 
subjected to DNase I (# 9PIM610, Promega) treatment. cDNA was synthesized starting from 0.5 μg 
treated RNA according to the High-Capacity cDNA Reverse Transcription Kit manual (#4368814; 
Applied Biosystems) and used for qRT-PCR. qPCR was performed using the Power SYBR Green 
PCR Master Mix (#4309155 Applied Biosystems). The primers used in qRT-PCR experiments are 
the following: 
Syn1 Fw 5’-AGCTCAACAAATCCCAGTCTCT-3’ 
Syn1 Rv 5’-CGGATGGTCTCAGCTTTCAC-3’ 
BDNF Fw 5’-ATTACCTGGATGCCGCAAA -3’ 
BDNF Rv 5’-TAATACTGTCACACACGCTCA-3’ 
BDNF-II Fw 5’-GCCATCCACACGTGACAAAAC-3’ 
BDNF-II Rv 5’- TGCTGAATGGACTCTGCTCTC-3’ 
SNAP25 Fw 5’-CCTAGTAGGTCTTGCACATACAC-3’ 
SNAP25 Rv 5’-GACAGAGCACACAGGACATTT-3’ 
NAV1.2 Fw 5’-GGCTCTGCTGTCATTGTTGGTA-3’ 
NAV1.2 Rv 5’-GAAGGCTAGGTGAGTACATCCC-3’ 
HPRT1 Fw 5’-TCAGTCAACGGGGGACATAAA-3’ 
HPRT1 Rv 5’-GGGGCTGTACTGCTTAACCAG-3’ 
GAPDH Fw 5’-AGGTCGGTGTGAACGGATTTG-3’ 
GAPDH Rv 5’-TGTAGACCATGTAGTTGAGGTCA-3’ 
RPS9 Fw 5’-CTGGACGAGGGCAAGATGAAGC-3’ 
RPS9 Rv 5’-TGACGTTGGCGGATGAGCACA-3’ 
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2.6 List of Plasmids (LOV-based probes) 
 
pCS2+MTmSin3AN205 was a kind gift from T. Kouzarides, Gurdon Institute, Cambridge, UK; and 
pCS2+PRIKLE1 was a kind gift from A. Bassuk, University of Iowa, Ames, IA. pcDNA3.1His-
AsLOV2 was cloned as follows: the AsLOV2 sequence was amplified from a bacterial plasmid 
encoding for AsLOV2 (gift from T. R. Sosnick, University of Chicago, Chicago) and inserted in the 
pcDNA3.1V5/His vector (Life Technologies) between the HindIII and AgeI sites. 
pcDNA3.1His/AsLOV2-PAH1 and pcDNA3.1His/AsLOV2-RILPshort were obtained as follows: 
the PAH1 sequence was amplified from pCS2+MTmSin3AN205 and cloned in pcDNA3.1His-
AsLOV2 at the AgeI site; the RILP N313 sequence was amplified from pCS2+PRIKLE1 and 
cloned in pcDNA3.1-His-AsLOV2 at the AgeI site. 
2.7 Lentivirus Production and Infection Procedures 
The lentiviral pCCL.sin.cPPT.PGK.GFP.WPRE bidirectional expression vector and packaging 
plasmids were a kind gift from L. Naldini, TIGET, San Raffaele Sci. Institute, Milan, Italy. For the 
coordinated expression of AsLOV2-PAH1b and GFP or of scrambled/REST shRNA and mCherry, 
the low-affinity nerve growth factor (NGF) receptor in the MA1 construct was replaced with REST 
cDNA, leading to GFP expression from the miniCMV promoter and REST expression from the 
phosphoglycerate kinase (PGK) promoter. Third-generation lentiviruses were produced by transient 
four-plasmid co-transfection into HEK293T cells using the calcium phosphate transfection method. 
Supernatants were collected, passed through a 0.45 μm filter, and purified by ultracentrifugation as 
previously described. Viral vectors were titrated at concentrations ranging from 1 × 10
8
 to 5 × 10
9
 
transducing units (TU)/mL and used at a multiplicity of infection (MOI) of 1–10. The efficiency of 
infection was estimated to range between 70% and 90% by counting neurons expressing GFP 
protein with respect to the total number of cells stained with DAPI. Primary cortical neurons were 
infected at 7 DIV. After 24 h, half of the medium was replaced with fresh medium. Experiments 
were performed 5–7 d after infection (between 12 and 14 DIV). 
2.8 Electrophysiological Recordings 
Primary cortical cultures were prepared from mouse C57BL/6J (E17–E18) embryos. All 
experiments were carried out in accordance with the guidelines established by the European 
Communities Council (Directive 2010/63/EU of 22 September 2010) and were approved by the 
Italian Ministry of Health. Lentivirus production and infection were performed following standard 
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procedures. Neurons were infected with lentiviral vectors encoding GFP, AsLOV2-PAH1b/GFP, 
scrambled/mCherry or REST shRNA/mCherry and subjected to 24 h light stimulation or kept in the 
dark. One day after the end of the stimulation protocol, excitability and Na
+
 current density were 
studied by patch-clamp recordings in current-clamp and voltage-clamp configurations. All 
experiments were performed on transduced neurons identified by green or red fluorescence using a 
Multiclamp 700B amplifier (Axon Instruments, Molecular Devices) and an upright bx51WI 
microscope (Olympus) equipped with Nomarski optics. Current clamp recordings were performed 
at a holding potential of −70 mV, and action potential firing was induced by injecting current steps 
of 25 pA lasting 500 ms. Sodium currents were obtained by stepping from a holding potential of 
−90 to −70 to +50 mV with 10 mV steps. 
 
2.9 Photostimulation Hardware and arduino sketch 
In vitro light stimulation experiments were performed using a custom built LED photostimulation 
device, which was fabricated with a precision-machined aluminum mounting plate and a 5 W high 
efficiency Blue LED array, with peak emission at 470 nm. LED intensity was regulated by a 
separate, 12 channel low-noise, linear power driver; on off operation (and duty cycle) was 
modulated by an ARDUINO 2000 microcontroller (the system can accept every TTL or digital 
positive signal to enable channels output or can be used in stand-alone mode). Radiation output was 
measured from a distance of 1.5 cm above the array using a Thorlabs PM100 power meter and an 
S121b circular sensor probe. 
ARDUINO sketch. 
// Assign channels to pins on the Arduino board 
const int pin1 = 2; 
const int pin2 = 4; 
const int pin3 = 6; 
const int pin4 = 8; 
const int pin5 = 10; 
const int pin6 = 12; 
 
// Define initial output states of pins.  For LED illumination, “LOW” means the LED is off, and 
“HIGH” //means it’s on 
int ledState1 = LOW; 
int ledState2 = LOW; 
int ledState3 = LOW; 
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int ledState4 = LOW; 
int ledState5 = LOW; 
int ledState6 = LOW; 
 
// Set reference timers for each channel to zero 
long prevMillis1 = 0; 
long prevMillis2 = 0; 
long prevMillis3 = 0; 
long prevMillis4 = 0; 
long prevMillis5 = 0; 
long prevMillis6 = 0; 
 
// Define pulse intervals for each channel 
long interval1 = 2000; 
long interval2 = 2000; 
long interval3 = 2000; 
long interval4 = 2000; 
long interval5 = 2000; 
long interval6 = 2000; 
  
// Define pulsewidth for each channel 
long pulse1 = 1000; 
long pulse2 = 1000; 
long pulse3 = 1000; 
long pulse4 = 1000; 
long pulse5 = 1000; 
long pulse6 = 1000; 
 
void setup(){ 
  // Define each pin as an output pin 
  pinMode(pin1,OUTPUT); 
  pinMode(pin2,OUTPUT); 
  pinMode(pin3,OUTPUT); 
  pinMode(pin4,OUTPUT); 
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  pinMode(pin5,OUTPUT); 
  pinMode(pin6,OUTPUT); 
   
} 
 
void loop(){ 
  // Assign  current time to time variables for each channel 
  unsigned long currentMillis1 = millis(); 
  unsigned long currentMillis2 = millis(); 
  unsigned long currentMillis3 = millis(); 
  unsigned long currentMillis4 = millis(); 
  unsigned long currentMillis5 = millis(); 
  unsigned long currentMillis6 = millis(); 
   
 
/* Code to determine on or off state of channel 1. If the current time is greater than the previously 
updated reference time by more than the defined interval, the LED turns on (“HIGH”) and the 
reference time gets updated to the present time (the time at which the LED turned on). If the LED 
had previously been triggered and the pulsewidth time has passed, the LED will turn off (“LOW”). 
The same script is used  below to control each individual channel*/ 
 
 if (currentMillis1-prevMillis1 > interval1) 
   { 
    
    if (ledState1 ==LOW){ 
      ledState1 = HIGH;   
      prevMillis1 = currentMillis1; 
    } 
   } 
    else { 
      if (currentMillis1-prevMillis1 > pulse1) 
      ledState1 = LOW;  
    }  
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// Control of channel 2    
if (currentMillis2-prevMillis2 > interval2) 
   { 
    
    if (ledState2 ==LOW){ 
      ledState2 = HIGH;   
      prevMillis2 = currentMillis2; 
    } 
   } 
    else { 
      if (currentMillis2-prevMillis2 > pulse2) 
      ledState2 = LOW;  
    }  
     
 
 // Control of channel 3 
 if (currentMillis3-prevMillis3 > interval3) 
   { 
    
    if (ledState3 ==LOW){ 
      ledState3 = HIGH;   
      prevMillis3 = currentMillis3; 
    } 
   } 
    else { 
      if (currentMillis3-prevMillis3 > pulse3) 
      ledState3 = LOW;  
    }  
     
     
 // Control of channel 4 
 if (currentMillis4-prevMillis4 > interval4) 
   { 
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    if (ledState4 ==LOW){ 
      ledState4 = HIGH;   
      prevMillis4 = currentMillis4; 
    } 
   } 
    else { 
      if (currentMillis4-prevMillis4 > pulse4) 
      ledState4 = LOW;  
    }  
    
    
  // Control of channel 5  
  if (currentMillis5-prevMillis5 > interval5) 
   { 
    
    if (ledState5 ==LOW){ 
      ledState5 = HIGH;   
      prevMillis5 = currentMillis5; 
    } 
   } 
    else { 
      if (currentMillis5-prevMillis5 > pulse5) 
      ledState5 = LOW;  
    }  
     
     
  // Control of channel 6 
  if (currentMillis6-prevMillis6 > interval6) 
   { 
    
    if (ledState6 ==LOW){ 
      ledState6 = HIGH;   
      prevMillis6 = currentMillis6; 
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    } 
   } 
    else { 
      if (currentMillis6-prevMillis6 > pulse6) 
      ledState6 = LOW;  
    }  
     
   
  // Output the state of each LED to the pins to physically regulate the LEDs 
  digitalWrite(pin1,ledState1); 
  digitalWrite(pin2,ledState2); 
  digitalWrite(pin3,ledState3); 
  digitalWrite(pin4,ledState4); 
  digitalWrite(pin5,ledState5); 
  digitalWrite(pin6,ledState6); 
   
} 
 
2.10 PUF vectors and cloning strategy 
 
PUF8wt and PUF16wt were kindly provided by Dr. Rackham (The University of Western 
Australia, Perth, Australia). PUFrest8, PUFrest8STACK(Y), PUFrest8STACK(H) and PUF16rest 
have been obtained starting from PCR amplification of PUF8wt and PUF16wt using Pfu DNA 
polymerase (#M7745; Promega) with the following mutagenesis primers: 
Fw PUF8rest-ns (SE-NQ) 5’-CAAATTTGCAAatAATGTTGTGcAGAAGTGTGTTACTC-3’ 
Rv PUF8rest-ns (SE-NQ) 5’-GAGTAACACACTTCTgCACAACATTatTTGCAAATTTG-3’ 
Fw PUF8rest-s 5’- GCATAAATTTGCCAATtACGTGGTTCAAAAATGTG-3’ 
Rv PUF8rest-s 5’-CACATTTTTGAACCACGTAATTGGCAAATTTATGC-3’ 
Fw PUF8rest-sH 5’- GCATAAATTTGCCAATCACGTGGTTCAAAAATGTG-3’ 
Rv PUF8rest-sH 5’-CACATTTTTGAACCACGTgATTGGCAAATTTATGC-3’ 
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For PUF16rest-ns: 
Fw Rep3(C-N) 5’- GGCACTGCAAATGTATGGTAATCGTGTTATTCAGAAAGCCCTGG-3’ 
Rv Rep3(C-N) 5’- CCAGGGCTTTCTGAATAACACGATTACCATACATTTGCAGTGCC-3’ 
Fw Rep4(N-C) 5’-GTGTGAAAGATCAGAATGGCTGTCATGTTGTGCAGAAATG-3’ 
Rv Rep4(N-C) 5’-CATTTCTGCACAACATGACAGCCATTCTGATCTTTCACAC-3’ 
Fw Rep14(NQ-SR) 5’-GTATGGAAGCTATGTGATTCGTCATGTTCTGGAACATG-3’ 
Rv Rep14(NQ-SR) 5’-CATGTTCCAGAACATGACGAATCACATAGCTTCCATAC-3’ 
Fw Rep12(SE-NQ) 5’-CAAATTTGCAAatAATGTTGTGcAGAAGTGTGTTACTC-3’ 
Rv Rep12(SE-NQ) 5’-GAGTAACACACTTCTgCACAACATTatTTGCAAATTTG-3’ 
PCR conditions were as follows: 95 °C, 5 min; 95 °C, 30 s; 55 °C, 30 s; 72 °C, 17, min; 30 cycles; 
72 °C 5 min. PCR products were digested using the DpnI enzyme (Promega) and transformed into 
DH5α cells. Positive colonies were verified by DNA sequencing. To avoid recombination events in 
PUF16rest-ns the mutations in REP3-4-6 were performed on PUF8wt while mutation in REP7 on 
PUF16wt. Mutated PUF16wt and PUF8wt were then digested with the SacI enzyme (Promega) and 
ligated with T4 DNA Ligase (Promega). PUF16rest-s and PUF16rest-2.0 were produced by 
BIOMATIK CORPORATION (Cambridge, ON, Canada). Mutated constructs were then amplified 
using Pfu DNA polymerase (#M7745, Promega) with the following primers, flanked by restriction 
sites for NotI and BamHI: 
Fw PUF8NotI 5’-GCATAAATTTGCCAATAACGTGGTTCAAAAATGTG-3’ 
Rv PUF8BamHI 5’-CACATTTTTGAACCACGTTATTGGCAAATTTATGC-3’ 
Fw:PUF16NotI 5’-CATAGCGGCCGCACCATGGGTCGTAGCCGTCTG-3’ 
Rv:PUF16BamHI 5’-CATAGGATCCGCCCAGGTCCACGCCATTTTTC-3’ 
and then cloned in the NotI /BamHI (Promega) digested CMV_3Xflag vector, kindly provided by 
Dr D. di Bernardo (Telethon Institute of Genetics and Medicine, TIGEM, Naples). Reporter 
plasmids for luciferase assays have been produced starting from annealed oligos: 1µg sense and 1 
µg antisense oligos were resuspended in the following solution: 10 mM Tris HCl (pH7.5), 0.1M 
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NaCl, 1mM EDTA, and incubated in a (Biorad T100 Thermocycler) as follows: 95°C 4min, 70°C 
10min, decrease temperature to 4° (0.1°C/min). 
 
RESTRNA8 
Sense 5’-TCGAGTTTATATAGC-3’ 
Antisense 5’-CGCCGCTATATAAA3-’ 
NRE 
Sense 5’-TCGAGTGTATATAGC-3’ 
Antisense 5’-CGCCGCTATATACAC-3’ 
RESTRNA16 
Sense 5’-TCGAGTGCTTTATATAAATTAGC-3’ 
Antisense 5’-CGCCGTAATTTATATAAAGCAC-3’ 
2XNRE 
Sense 5’-TCGAGTGTTGTATATAATATAGC-3’ 
Antisense 5’-CGCCGTATATTATATACAACAC-3’ 
Annealed oligos were inserted via standard ligation procedures in the digested XhoI /NotI 
psiCHECK Vector 2.0, provided by Dr A. Contestabile (Istituto Italiano di Tecnologia, IIT Genoa). 
2.11 Purification of Flag-tagged Proteins 
 
Cytosolic protein lysate (300 µg) was purified with 30 µl of Anti-FLAG® M2 Magnetic Beads 
(Sigma-Aldrich) pre washed with PBS/tween 0.1%, and incubated in the following solution: 50 mM 
Tris HCl,150 mM NaCl, pH 7.4; in a total volume of 200 l for 2 h RT. After incubation, beads 
were washed five times with PBS/tween 0,1%, and bound proteins were eluted by incubation with 
3X FLAG peptides (# F4799, Sigma) (150 ng/µl final concentration) for 45 min at 4 °C. 6% of the 
total volume elution was resolved on a denaturing 10% polyacrylamide gel and stained with 
Pierce™ Silver Stain Kit (#24612 Thermo Fisher Scientific) for purity rate verification. The final 
protein concentration was quantified by using the BCA protein assay kit (#23225; Pierce Biotech.). 
2.12 RNA Electrophoretic mobility shift assay (EMSA) 
 
3’biotinylated RNA sequences (NRE: CCUGUAUAUAAGU; RESTRNA8: 
CCUUUAUAUAAGU; 2XNRE: CCUGUUGUAUAUAAUAUAAGU; RESTRNA16: 
CCUGCUUUAUAUAAAUUAAGU; RESTRNA16-2.0 CCAUUGGCUUAGUAAAUUAGU) 
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were chemically synthesized (Sigma Aldrich). To perform EMSAs, the LightShift® 
Chemiluminescent RNA EMSA Kit (#20158, Thermo Fisher Scientific) was used. For each gel-
shift reaction, a total of 10 nM biotin-labeled probe was dissolved in the Binding Buffer provided, 
supplemented with glycerol 50%, 2 g tRNA, BSA 4 µg, KCl 50mM, DTT 2 mM, Tween 0.02%, 
EDTA 1 mM, and incubated with 1 µM -10 µM of purified proteins. The reaction mixture was pre-
incubated 40 min at RT and resolved on a non-denaturing 10% polyacrylamide gel 0.5X TBE (1h 
4°C) that had been pre-electrophoresed for 60 min. RNA-protein complexes were transferred to 
nylon membranes and then crosslinked for 13 min using a commercial UV-light crosslinking 
instrument (254 nm bulbs). To obtain titration curves, known concentrations of biotin-labeled RNA 
(2.5-5-10-20-40-80-160 pg) were used to create a standard curve from which the complexed RNA 
concentration was interpolated. Data were then fitted using nonlinear regression analysis with the 
following formula Y=Bmax*X^h/(Kd^h + X^h), thus obtaining Kd values. 
 
2.13 Cross-linking RNA Immunoprecipitation (CLIP) 
 
Transfected N2a cells (1x10^6) were subjected to UV crosslink at 4000x100 J/cm^2. Cells were 
subsequently harvested in buffer A [20 mM Tris HCl (pH 8), 10 mM NaCl, 3mM MgCl2, 0.1% 
NP40, 10% Glycerol, 0.2 mM EDTA, 1 mM DTT, protease inhibitor mixture tablets 
(#04693116001, Roche), RNase inhibitor RiboLock (#EO0381 Thermo Scientific)] and centrifuged 
at 2500 x g at 4°C for 5 min. Agarose beads protein A salmon sperm (#16-157. Millipore) were pre-
cleaned with CLIP Buffer (1XPBS, 0.1% SDS 0.5% NP-40) and incubated for 1 h with the lysates 
plus RIPA buffer (10 mM Tris·HCl, pH 7.5, 1 mM EDTA, 140 mM NaCl, 0.5 mM EGTA, 1% 
TritonX-100, 0.1% SDS, 0.1% Na-deoxycolate) to a final volume of 1mL. After centrifugation at 
2500 x g for 5 min, the supernatant was divided in two equal parts, to incubate with anti-flag Rabbit 
(#F7425 SIGMA) (5 g) and anti-rabbit IgG antibodies (PP54B; Millipore) (2.5 g) at 4°C 
overnight, (keeping 50 µl for Input RNA Real time detection and 20µl for Input protein WB 
detection). Pre-cleaned beads were incubated with the antibody-protein-RNA complex at 4 °C for 2 
h. Beads were washed with CLIP Buffer and High Salt wash buffer [5XPBS without 
Mg
2+
/Ca
2+
(#D1408, Sigma-Aldrich), 0.1% SDS, 0.5% NP-40], and resuspended in RIPA buffer. 
Proteinase K (#P6556, Sigma-Aldrich) was added to the samples and incubated 45 min at 45 °C 
before proceeding to RNA extraction by using the miRNeasy kit (#217004, Qiagen). 50% of the 
total RNA extracted volume was used for cDNA synthesis and qRT-PCR. List of primers used in 
qRT-PCR: 
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FwREST3’UTR: 5’-GCATAAATCTTAGCAAATCCTCGGGAG-3’ 
RvREST3’UTR: 5’-GGCAGACAAGGCAAGTGGTGTG-3’ 
FwGapdh3’UTR: 5’-GAAACCCTGGACCACCCAC-3’ 
RvGapdh3’UTR: 5’-GTGGGTGCAGCGAACTTTATTG-3’ 
FwRESTCDS: 5’-TTCACATTTATACGGGCGTTC-3’ 
RvRESTCDS: 5’-CCTGCAGCAAGTGCAACTAC-3’ 
FwGapdhCDS: 5’-AGGTCGGTGTGAACGGATTTG-3’ 
RvGapdhCDS: 5’-TGTAGACCATGTAGTTGAGGTCA. -3’ 
 
2.14 Molecular Dynamics Simulations 
 
The starting conformation of the PUF8wt system was obtained from the PDB structure (3Q0P) and 
not from PDB (1M8Y), (same amino acid sequence) since this structure was more correct for 
simulations. PUF16wt was generated by hand as described in par. 3.2.2. All required protein and 
RNA mutations were performed using the VMD program by deleting the original sidechain atoms 
and letting VMD generate the positions of the new atoms. When overlaps were observed, the 
structure was optimized by hand based on local alignment with similar crystal structures. All 
systems were solvated in explicit water using the TIP3P water model, and the total charge was 
neutralized by adding Na+ and Cl–ions at physiological concentration. The total number of atoms, 
including water and ions, was 130,000 for PUF8wt and 290,000 for PUF16wt. Periodic Boundary 
Conditions were used to avoid finite-size effects, and long range electrostatic interactions were 
treated with the Particle Mesh Ewald method. For each system, the internal energy was minimized 
via 1000 steps of steepest descent and then 2 ns of equilibration were performed at constant 
pressure and temperature (NPT ensemble) with pressure 1 atm and temperature 300K. A timestep of 
2 fs was used. Finally, production runs were carried out in the constant volume and temperature 
NVT ensemble, for a total of 200 ns per system. All simulations were performed with the NAMD 
program and using the Amber force field. All analyses were carried out with VMD, and distances 
and energy contributions were calculated using home-written Tcl scripts. 
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2.15 Statistical Analysis 
 
Results are expressed as means ± S.E.M. throughout. Data were analyzed by either the unpaired 
Student's t test or one-way ANOVA followed by Tukey's multiple comparison test. 
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3 Results 
3.1 Transcriptional modulation of REST activity   
3.1.1 Design of AsLOV2-based strategies to inhibit REST activity. 
 
To modulate REST activity, we engineered chimeric proteins formed by the light-sensitive 
AsLOV2 protein fused to two REST-interfering domains. AsLOV2 would sterically block the 
effector domain fused to its C terminus in the dark, whereas the unfolding of the Jα-helix upon 
illumination would cause the reversible exposure of the effector sequence (Fig. 3.1a). To select 
REST-interfering molecules, we focused on domains able to alter two key events in REST activity, 
namely the recruitment of the cofactor mSin3a and the REST-RE1 site interaction. To impair 
mSin3a recruitment, we used the N-terminal portion of mSin3a (mSin3a-N205), which was 
identified as the minimal REST binding region of mSin3a [77] (AsLOV2-PAH1). To interfere with 
RE1 recognition, we chose the REST-interacting LIM domain protein (RILP), an endogenous 
REST interactor that, by binding to the Zn-finger domains of the repressor, displaces it from the 
target chromatin [78]. We used the first N-terminal portion of RILP (RILP-N313), which contains 
the minimal REST binding domain (AsLOV2-RILP N313) (Fig. 3.1b). 
 
37 
 
 
 
Figure 3.1 Strategies for REST inhibition. a Schematic cartoon of the inhibition strategy. mSin3a (Upper) 
or RILP (Lower) interfering domains are directly fused to AsLOV2. In the dark, AsLOV2 is in a closed 
conformation, masking the REST-binding sites. Upon blue light illumination (470 nm), AsLOV2 unfolds 
thus freeing the C-terminal domains to interact with REST, displacing the endogenous mSin3a or the entire 
REST complex from target DNA. This would result in the increased transcription of REST-target genes. b 
Schematic representation of REST, mSin3a, and RILP protein sequences. The interacting portions between 
REST and mSin3a/RILP are highlighted. PAH1, paired amphipathic helix 1; PET, Prickle Espinas Testin; 
LIM, Lin11, Isl-1, andMec-3. 
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3.1.2 Light-Driven Modulation of REST Activity 
 
Once the expression and the REST interfering activity of the two chimeras (AsLOV2-PAH1 and 
AsLOV2-RILP N313) had been validated, we evaluated the activity of the AsLOV2 constructs in 
response to specific patterns of illumination. N2a cells were transfected with AsLOV2-PAH1 and 
AsLOV2-RILP N313 and after 24 h, cells were transferred to the illumination apparatus and 
subjected to the light stimulation protocol (470-nm light illumination 0.5 Hz) (Fig. 3.2a). A 
significant increase in the transcription of the REST targets BDNF, BDNFII, SYN1, SNAP25, and 
NAV1.2 mRNAs was observed upon illumination in cells expressing either chimera. No increase in 
gene transcription was observed in parallel samples kept in the dark or in control cells transfected 
with AsLOV2 alone and exposed to the same illumination pattern (Fig. 3.2a). Next, we wanted to 
define the time course of the light-induced transcriptional changes from the beginning of the light 
stimulation protocol up to a maximum time of 48 h, using BDNF as a target gene. We found that, 
with both AsLOV2 chimeras, BDNF expression levels significantly increased already after 12 h of 
illumination, reached a plateau of ∼1.5- to 2-fold increase after 24 h and returned to baseline levels 
in ∼12 h after switching off the light (Fig. 3.2b). To evaluate whether the observed changes in 
mRNA levels were followed by a parallel change in protein levels, BDNF protein was measured in 
cell extracts by western blotting after 48 h of light stimulation. As expected, a significant increase in 
BDNF protein was observed only in N2a cells expressing the active probes and exposed to light 
(Fig. 3.2c). Taken together, these data demonstrate that both AsLOV2-PAH1 and AsLOV2-RILP 
N313 effectively act as light modulated inhibitors of REST activity on target genes, resulting in 
increased levels of transcription and translation. 
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Figure 3.2 Photostimulation of AsLOV2-PAH1 and AsLOV2-RILP N313 constructs. a Illustration of 
the illumination protocol and LED stimulation apparatus. Undifferentiated N2a cells were transfected with 
the indicated constructs. Cells were subjected to 470-nm light illumination (0.5 Hz) or kept in the dark, as 
indicated. After 48 h, the mRNA levels of the indicated genes were quantified via qRT-PCR. GAPDH and 
HPRT1 were used as control housekeeping genes (*P < 0.05; **P < 0.01; Student t test; n = 3 independent 
experiments). b Time-course of light-dependent BDNF up-regulation and post illumination recovery (*P < 
0.05; Student t test vs. respective dark condition; n = 3 independent experiments). c Western blot analysis of 
BDNF in undifferentiated N2a cells transfected with the indicated constructs.  
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3.1.3 Transduction of AsLOV2-PAH1 in Primary Neurons Increases 
Intrinsic Excitability. 
To study the effects of the light-driven modulation of REST in primary neurons, we engineered a 
bidirectional lentiviral vector expressing AsLOV2-PAH1 and EGFP. Once transduced into primary 
neurons, the probe showed a clear enrichment in the nuclear compartment as we expected (Fig. 
3.3a). Primary cortical neurons were infected at 7 d in vitro (DIV) and then subjected to 470-nm 
light stimulation at 12 DIV for 24 h. Starting from the illumination parameters used for N2a cells, 
we optimized our protocol for primary neurons, by changing both the illumination intensity and the 
duty cycle. We found that the optimal conditions for primary neurons, which maximized cell 
viability while inducing appreciable changes in gene transcription, were 0.34 mW/cm2; 250-ms 
pulses; 0.25 Hz. The analysis of gene transcription reported a significant increase in both NAV1.2 
and BDNF mRNAs in AsLOV2-PAH1 infected neurons exposed to light compared with the same 
neurons kept in the dark or to neurons infected with a control vector expressing only EGFP (Fig. 
3.3b), indicating that the lentiviral probe was effective in inhibiting REST activity in primary 
neurons. Next, we analyzed whether the optogenetic suppression of REST activity was associated 
with changes in intrinsic neural excitability. Transduced neurons, held at a membrane potential of –
70 mV in whole-cell current-clamp mode were subjected to current injection of 500-ms duration 
and stepwise increasing amplitude. Interestingly, neurons expressing AsLOV2-PAH1 and subjected 
to light stimulation displayed a strongly increased firing frequency compared with the same 
transduced neurons kept in the dark or to parallel cultures infected with the control vector (Fig. 
3.3c). Interestingly, the increase in the firing frequency obtained by optogenetic inhibition of REST 
activity with either probe was fully comparable with that obtained by silencing REST with a 
lentiviral vector expressing a REST shRNA (Fig. 3.3d). These observations demonstrate that the 
AsLOV2-PAH1 probe is able to influence REST activity in primary neurons by inducing light-
evoked transcriptional regulation with functional consequences on neuronal activity. 
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Figure 3.3 AsLOV2-PAH1 inhibits REST activity in primary neurons. a Confocal images of primary 
cortical neurons infected with a bidirectional lentiviral vector expressing either EGFP (CTRL) or AsLOV2-
PAH1/EGFP. Neurons were stained using anti-Histidine tag antibodies (red) to detect the AsLOV2 construct, 
and anti-EGFP (green) antibodies to detect EGFP Scale bar, 10 μm.b (Upper) Schematic representation of 
the time course of the experiment: neurons were infected at day 7, the illumination protocol was started 5 d 
after infection (day 12) for 24 h. (Lower) qRT-PCR for NAV1.2 and BDNF mRNA in EGFP (CTRL) or 
AsLOV2-PAH1–expressing neurons kept under dark (gray bars) or lit (blue bars) conditions for 24 h. 
GAPDH and HPRT1 were used as control housekeeping genes (*P < 0.05; one-way ANOVA followed by 
the Tukey’s multiple comparison test vs. the respective dark control; n = 3 independent experiments ).c. Plot 
of the mean (±SEM) firing frequency vs. injected current (F/I curve) in cortical neurons infected with either 
AsLOV2-PAH1 (closed symbols) or EGFP alone (CTRL, open symbols) and subjected to either 24 h light 
(blue symbols) or 24 h dark (gray symbols) (AsLOV2-PAH1/dark, n = 22; AsLOV2-PAH1/light, n = 21; 
EGFP/dark, n = 19; EGFP/light, n = 20; from 3 independent experiments). Representative current-clamp 
recordings of spike trains evoked by injection of 225 pA for 500 ms in neurons infected with AsLOV2-
PAH1 and kept for 24 h under dark (black) or lit (blue) conditions are shown on the left. d The same 
experiment was performed in neurons infected with either a scrambled shRNA or shRNA against REST (n= 
11 for each condition). 
.
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3.2  Targeting REST at the transcriptional level 
3.2.1 Design of synthetic PUF proteins specific for REST mRNA 
 
The above-described results show that we were able to modulate REST activity by using two light-
sensitive chimeras that interfered with the interaction between REST and its cofactor mSin3a, or 
inhibited REST binding to target gene promoters, thus decreasing indirectly REST activity in a 
light-sensitive way. In order to increase REST expression, we decided to modulate directly REST 
mRNA by engineering a REST RNA-specific binding protein. To this aim, we used the PUF protein 
PUMILIO-Homology Domain from Human Pumilio1 (HsPUM-HD), whose amino acidic sequence 
and secondary structure have been well characterized, since the crystallographic structure of the 
protein in complex with the RNA sequence is availabile (PDB code 1M8Y). The chosen PUF 
recognizes an eight ribonucleotide RNA sequence (5’UGUAUAUA3’) called Nanos Response 
Element (NRE)[79]. PUF binds every RNA base through a single repeat for a total of eight 
repetitions. In this work, the wild type PUF protein is referred to as PUF8wt. We analyzed the 
3’UTR of mouse REST mRNA (713 bp) to select a PUF target sequence that minimized the number 
of mutations required to achieve specific binding, while conserving the original folding (Fig. 3.4a). 
In addition we selected a sequence that is not overlapping with, or in close proximity to, miRNA 
sites. Eventually, we identified a sequence of eight ribonucleotides that diverges from the original 
PUF target for only one base, i.e. 5’UUUAUAUA3’, which we call RESTRNA8. Naturally 
occurring PUF proteins typically contain eight RNA-binding repeats that allow them to regulate 
specific developmental processes, often by binding multiple RNAs [80]. With the aim of 
minimizing the off-targeting and increasing the sequence specificity of our REST-specific 
construct, we took advantage of a PUF protein composed of 16 RNA-binding repeats, referred to as 
PUF16wt, kindly provided by Dr. Rackham (The University of Western Australia, Perth, Australia). 
This extended PUF is composed of two HsPUM-HD, and binds to a double NRE sequence 
(5’UGUUGUAUAUAAUAUA3’, 2XNRE)[62]. 
The REST-specific PUF16 protein target was built on a sequence spanning RESTRNA8, 
three additional ribonucleotides at 5’ and other five ribonucleotides at the 3’, obtaining a 16 bp 
sequence (5’UGCUUUAUAUAAAUUA3’, RESTRNA8 sequence in red, additional nucleotides in 
black) that differs from 2XNRE in four base pairs. In addition, to evaluate the feasibility of 
engineering PUF proteins for any RNA sequence irrespective of the similarity to the original NRE 
site, we picked also a 16 bp sequence in REST 3’UTR, 5’AUUGGCUUAGUAAAUU3’ that we 
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defined RESTRNA16-2.0, characterized by minimal cross-talk across all mouse mRNAs (Fig. 3.4a). 
Since there are no structural data about the extended PUF domain, we coupled biological 
experiments with computational molecular modeling in order to support our future experiments. 
Computational analyses over both PUF8 and PUF16 systems (detailed in the next sections) were 
performed in collaboration with Drs. M. Gatti and L. Maragliano, (IIT-NSYN, Genova) by 
engineering a 3D model of PUF16wt together with the PUF8wt model, whose crystallographic 
structure is available (PDB code 1M8Y) (Fig 3.4b). 
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Figure 3.4 Sequence of REST mRNA 3’UTR and 3D model of PUF8wt and PUF16wt. a. REST 3’UTR 
RNA sequence (713bp, NCBI #ENSMUSG00000029249). RESTRNA8 is highlighted in red, RESTRNA16, 
spanning RESTRNA8 and flanking ribonucleotides, is marked by the black rectangle. The sequence of 
RESTRNA16-2.0 is in blue. b. Left: PUF8wt crystal structure bound to the NRE sequence (PDB code 1M8Y). 
Right: 3D structural model of the PUF16wt, built from 2 PUF8wt domains, in complex with 2XNRE. The 
protein backbone is represented in blue and the ribonucleotide sequence in red; protein residues involved in 
the recognition code are highlighted in cyan (kindly provided by Drs M. Gatti and L. Maragliano, IIT-
NSYN, Genova). 
 
 
REST mRNA 3’UTR 
CUGAGCCUCGGCAGAAGCACCGUGCAGACUUUGUGAGCAUGCAAUUUUAA
UUUGUAGACAAACGCAAGCUUGCUUUAAUUAGUCUCCAAGGCUGAGUUUU
CAGUAACAUUCUUUUUCUUAGGACUGUACAUCUAUUUAGUGUUUGUUGCA
UAAAUCUUAGCAAAUCCUCGGGAGUUAAUGUAAGAGGACAGAUAUGUAAC
UAGCUCGUGCAGGCAGGUGCAAGGAGAAGGGUAAGAUGGUGGAACACACC
ACUUGCCUUGUCUGCCUACAACCUGUUGGGUUUUCUUUUCACGGUAGUUC
CUAAUUUUUAGUUACUUGUUUAGAUCGAUAAAAAUUGGCUUAGUAAAUUA
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We then mutagenized PUF8wt and PUF16wt through site-directed mutagenesis to obtain 
proteins able to bind the REST selected sequences. According to Cheong et al [81], a single PUF 
repeat (R) binds its specific ribonucleotide using two amino acid side chains, at the position 12 and 
16 (the first and last residues in the five-residue code shown in Fig. 1.6a), which make hydrogen 
bonds or van der Waals contacts with the Watson–Crick edge of the RNA base; a third amino acid 
side chain, at position 13 (the second residue in the five-residue code shown in Fig. 1.6a), makes 
stacking interactions with the aromatic rings of the RNA base. In many studies, artificial PUFs are 
designed changing only the hydrogen-bonding amino acid residues, which is sufficient to achieve 
specificity for a new sequence [82, 83]. However the residue mediating the stacking interactions 
with the aromatic rings can also affect the affinity for the target RNA [84]. In order to elucidate the 
importance of the stacking residues in the PUF/RNA recognition mechanism, we engineered two 
variants of synthetic REST-PUF proteins, one mutated in hydrogen bonds or van der Waals 
residues, which we referred as “ns” (not stacking) and another one mutated in hydrogen-bonding 
and stacking amino acid residues referred as “s” (stacking). Therefore, based on the RNA-
recognition code of PUF proteins (Fig. 1.6), we replaced the serine and the glutamic acid of 
PUF8wt in repeat R7 with an asparagine and a glutamine at position 12 and 16 (SE to NQ), 
obtaining PUF8rest-ns (Fig. 3.5a). We then replaced the asparagine at position 13 with a tyrosine 
(N-Y) obtaining PUF8rest-s, and according to the expanded recognition code in artificial PUF 
scaffolds (5) we also replaced the same asparagine with a histidine (N-H), which is the second most 
frequent amino acid after tyrosine in repeat R7, thus obtaining PUF8rest-sH (Fig. 3.5a). 
Following the same approach used for PUF8wt, we mutated the hydrogen-bonding amino 
acid residues at position 12 and 16 of repeats R14, R12, R4 and R3 of PUF16wt, obtaining 
PUF16rest-ns (Fig. 3.5b). Specifically, in repeat R14 we replaced asparagine and glutamine with 
serine and arginine (NQ to SR); in repeat R12 serine and glutamic acid with asparagine and 
glutamine (SE to NQ), in repeat R4 asparagine with cysteine (N to C), in repeat R3 cysteine with 
asparagine (C to N) (Fig. 3.5b). We also modified the stacking residues, creating the PUF16rest-s 
protein, in which we replaced asparagine with tyrosine (N to Y), in repeat R12, tyrosine with 
arginine (Y to R) in repeat R4, and arginine with tyrosine (R to Y) in repeat R3 (Fig. 3.5b). We also 
engineered a PUFrest16-2.0 specific for binding the RESTRNA16-2.0 sequence. In this case, we 
changed the amino acids at position 12, 13 and 16, according to the code, to achieve the specificity 
for the new sequence (Fig. 3.5c). 
In summary, we have engineered a total of six REST-specific PUF proteins of which three 
are designed to bind RESTRNA8, i.e. PUF8rest-ns, PUF8rest-s, PUF8rest-sH, two to bind 
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RESTRNA16, i.e. PUF16rest-ns and PUF16rest-s, and one for RESTRNA16-2.0, i.e. PUFrest16 2.0. 
PUF8wt and PUF16wt with their cognate sequences have been used as controls in all the 
experiments described in the next sections. 
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Figure 3.5 Schematic representation of the PUF constructs. a. NRE target sequence and the amino acids 
at position 12, 16 and 13 (stacking) within each of the eight repetitions of PUF8wt. RESTRNA8 differs from 
NRE for one ribonucleotide (uracil) corresponding to repeat R7. The mutations performed to obtain the three 
REST-specific PUF8 proteins are represented in red: amino acid 12 and 16 for PUF8rest-ns, amino acids 12, 
13 and 16 for PUF8rest-s and PUF8rest-sH. b. 2XNRE target sequence and the amino acids at position 12, 16 
and 13 (stacking) within each of the sixteen repeats of PUF16wt. RESTRNA16 differs from 2XNRE in four 
ribonucleotides corresponding to repetitions R14, 12, 4 and 3 (in red). The mutations performed to obtain the 
two REST-specific PUF16 proteins (PUF16rest-ns and PUF16rest-s) are highlighted in red. c. PUF16rest-2.0 
with its own target sequence RESTRNA16-2.0. 
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3.2.2 Structural modeling of PUF16wt in complex with its cognate 
2XNRE sequence 
 
A 3D model of the extended PUF domain (PUF16wt), was built starting from two identical PUF 
proteins and joining them by creating new chemical bonds using the PSFgen Plugin of the VMD 
program [85], employing the same strategy described in Filipovska et al [62]. The first five repeats 
(R1 to R5) were selected and cut at the end of the R5 repeat and the same procedure was applied for 
the last three (R6-R8). The proper number of residues to cut was carefully determined by using the 
Uniprot structure domain section of the PUF8wt 
(http://www.uniprot.org/uniprot/Q14671#structure) as reference. The second PUF protein was kept 
as a whole, without the flanking regions, in such way to allow the newly cut parts from the first 
PUF protein to be fused and, at the same time, preserving the modular structure (Fig. 3.6). The 
same procedure was applied for the RNA molecule. 
 
 
Figure 3.6: Left: Schematic representation of the extended PUF16wt structural model built according to 
Filipovska et al.[62]. Right: 3D structure of PUF16wt coupled with the 16 bp 2XNRE sequence, built using 
the VMD software (images kindly provided by Drs M. Gatti and L. Maragliano, IIT-NSYN, Genova). 
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3.2.3  The REST-designed PUF proteins are expressed and localize in 
the cytosol 
 
As a first step in the validation of the engineered PUF constructs, we checked whether they are 
correctly expressed in mammalian cells. To this aim, we transfected the various constructs in 
HEK293T cells and analyzed the expression of the PUF proteins by western blotting analysis using 
anti-flag antibodies (expected MWs: eight-repeat PUF constructs, 47 kDa; sixteen-repeat PUF 
constructs, 75kDa). We detected good expression levels of all the proteins (Fig. 3.7a). We 
subsequently purified the proteins starting from mammalian cells, since it has been demonstrated 
that some mutations may affect the protein solubility and the efficiency of production in bacteria 
[82] Proteins isolated from transfected HEK293T cells were analyzed by denaturing polyacrylamide 
gel electrophoresis (SDS-PAGE) and visualized by silver staining, showing a satisfactory 
purification rate (Fig. 3.7b). Finally, to verify the intracellular localization of the new constructs, 
we transfected HEK293T cells and performed immunostaining and confocal analysis using anti-flag 
antibodies to mark the PUF proteins. All the proteins localized in the cytosol, as expected (Fig. 3.8). 
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Figure 3.7. REST-designed PUF proteins expression and purification. a. HEK293T cells were 
transfected with the indicated PUF constructs. NC = negative control (cells transfected with the empty Flag 
vector). Protein expression was analyzed by western blotting using anti-Flag antibodies and antibodies for 
the housekeeping genes calnexin and gapdh. b. Silver-stained gel of the PUF constructs after 
immunoprecipitation with anti-flag beads. Cytosolic extracts were incubated with magnetic beads conjugated 
to anti-Flag antibodies, eluted with 3x flag peptides and analyzed on a 10% polyacrylamide gel, subsequently 
silver-stained. 
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Figure 3.8. REST-designed PUF proteins intracellular localization. Confocal images of HEK293T cells 
transfected with the indicated constructs were processed for indirect immunofluorescence using anti-Flag 
antibodies (red) to detect PUF constructs and Hoechst (blue) to visualize cell nuclei. The overlay images 
(merge) reveal the cytosolic localization of the constructs. Scale bars: 10 m in the lower magnification 
panel, 10 m in the higher magnification panels. 
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3.2.4  Eight- and sixteen-repeat PUF constructs mutated in the 
stacking residues bind to REST sequences 
 
To verify whether the designed PUF constructs were able to bind specifically their cognate 
sequences, we performed electrophoretic mobility shift assay (EMSA) analysis using a constant 
concentration of purified PUF proteins (1 µM) with biotinylated RNA targets. For the eight-repeat 
constructs (PUF8rest-ns, PUF8rest-s and PUF8rest-sH), the target RNA sequences were NRE and 
RESTRNA8. For the sixteen-repeat constructs, the target RNA sequences were 2XNRE and 
RESTRNA16 for PUF16wt, PUF16rest-ns, PUF16rest-s and RESTRNA16-2.0 for PUFrest16-2.0. 
We first checked the binding of every PUF construct for its cognate and non-cognate 
sequences (Fig. 3.9). For what concerns the 8-repeat constructs, we observed the formation of a 
specific RNA-protein complex between PUF8rest-s and PUF8rest-sH with RESTRNA8, while we 
did not detect any binding to NRE. Vice versa, we observed the formation of a specific complex of 
PUF8wt with NRE and not with RESTRNA8. However, we did not observe any RNA-protein 
complex for PUF8rest-ns with any of the target sequences, even when the concentration of 
PUF8rest-ns used in the assay was raised from 1 to 10 µM (Fig. 3.9a-b). Similar results were 
obtained when EMSA was performed with the 16-repeat constructs. In this case, we observed the 
formation of a specific complex of PUF16rest-s with RESTRNA16, and of PUF16wt with 2XNRE, 
and not with their non-cognate sequences. No RNA-protein complexes were detected for 
PUF16rest-ns and PUFrest16-2.0 with any of the sequences (Fig. 3.9c), not even when the PUF 
concentration used in the assay was increased to 10 µM (Fig. 3.9d). 
Altogether, this first series of experiments shows that mutations in the stacking residues are 
indeed crucial to confer binding specificity to REST-PUF constructs, compared to the same 
constructs mutated only in the backbone residues. Therefore all the subsequent experiments were 
restricted to these two proteins. 
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Figure 3.9 Evaluation of PUF proteins specificity by EMSA analysis. a. The indicated 8-repeat PUF 
proteins were incubated with biotinylated NRE (N) and RESTRNA8 (R8) ribonucleotide sequences. Protein-
RNA complexes and unbound RNA are indicated. b. Increasing concentrations of PUF8rest-ns were 
incubated with N and R8 sequences, as indicated. c. The indicated 16-repeat PUF proteins were incubated 
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with biotinylated 2XNRE (2N), RESTRNA16 (R16) and RESTRNA16-2.0 (R2.0) ribonucleotide sequences. 
Protein-RNA complexes and unbound RNA are indicated. d. Increasing concentrations of PUF16rest-ns 
were incubated with 2N and R16 sequences (upper panel), and PUF16rest-2.0 with R16 and R2.0, as 
indicated. Biotinylated sequences used in the assays are indicated below the EMSA gels in (a) and (c). 
highlighted in bold black. 
 
 
3.2.5 Eight- and sixteen-repeat PUF proteins mutated in the stacking 
residues bind to REST RNA with high affinity 
 
We next determined the binding affinity of the REST-PUF constructs that showed the highest 
affinity for their target sequences, i.e. PUF8rest-s and PUF16rest-s, and compared them to the 
respective wt constructs, i.e. PUF8wt and PUF16wt. We performed EMSA experiments by 
increasing the concentration of PUF proteins up to 10 µM, in the presence of molar excess of target 
RNAs. The amount of RNA bound to proteins was quantified by densitometric analysis and 
absolute amounts (ng) were extrapolated by running in the same blot an RNA titration curve. The 
amount of bound RNA (ng) was subsequently plotted as a function of PUF protein concentration 
(M), and data fitted by non-linear regression (see Materials and Methods and legends to Fig. 3.10 
and Fig. 3.11). We measured the equilibrium dissociation constant for all the analyzed systems. Our 
results indicate that PUF8wt binds NRE with the highest affinity (Kd = 1.3 µM) (Fig. 3.10a), while 
PUF8rest-s has a lower affinity for RESTRNA8 (Kd = 3.4 µM) despite the fact that it binds more 
RNA (Bmax = 0.8 ng vs 0.020 ng for PUF8wt) (Fig. 3.10b). For what concerns the 16-repeat 
constructs, instead, we obtained a Kd of 4.1 µM for PUF16wt and of 2.6 µM for PUF16rest-s. Thus, 
in this case, the REST-specific construct bound its target sequence with a higher affinity than its wt 
counterpart (Fig. 3.11). 
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Figure 3.10 Binding isotherms of eight-repeat PUFs to their target RNA sequences. a Left panel: 
Binding of PUF8wt induces a mobility shift in biotinylated NRE. Right panel: The amounts of PUF-bound 
cognate RNA, plotted as a function of the purified PUF8wt protein concentration, were quantified in relation 
to known quantity of biotinylated RNA. Data, shown as means ±SD of two independent experiments, were 
fitted by nonlinear regression using the one site specific binding with hill slope model Y=Bmax*X^h/(Kd^h 
+ X^h). b The same analysis was performed for PUF8rest-s with biotinylated RNAREST8. 
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Figure 3.11 Binding isotherms of sixteen-repeat PUFs to their target RNA sequences. A. Left panel: 
Binding of PUF16wt induces a mobility shift in biotinylated 2XNRE. Right panel: The amounts of PUF-
bound cognate RNA, plotted as a function of the purified PUF16wt protein concentration (1-10 µM), were 
quantified in relation to known quantity of biotinylated RNA. Data, shown as means ± SD of two 
independent experiments, were fitted by nonlinear regression using the one site specific binding with hill 
slope model Y=Bmax*X^h/(Kd^h + X^h) b. The same analysis was performed for PUF16rest-s with 
biotinylated RNAREST16. 
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3.2.6 Molecular dynamics simulations of PUF-RNA interaction 
 
In order to investigate in detail the structural determinants of the PUF/RNA interactions, structural 
modeling and Molecular Dynamics (MD) simulations of the PUF/RNA complexes were performed 
in collaboration with Drs. M. Gatti and L. Maragliano, (IIT-NSYN, Genova). Using MD, it is 
possible to reconstruct the time evolution of a system by employing mathematical and physical 
models based on Newtonian dynamics. These simulations are usually performed starting from the 
3D atomic structure of a system obtained from X-Ray crystallography, and allow gaining insights 
on the atomistic details at the basis of the molecular interactions. For the 8-repeat PUF systems the 
crystal structure of the PUMILIO-homology domain from Human PUMILIO1 with hunchback NRE 
(PDBcode: 3Q0P) was used, while the 16-repeat structures were modeled starting from two copies 
of the same crystal that were fused as described above. All systems were simulated using the Amber 
force field [86] and the NAMD [87] software packages. The VMD program [85] was used to 
visualize the 3D structures and analyze the trajectories. Here we show simulations only for the PUF 
constructs whose RNA specificity was described in the previous section. Thus, three simulations 
were produced for the 8-repeat constructs: PUF8wt-NRE, PUF8wt-RESTRNA8, PUF8rest-s-
RESTRNA8, and three for the 16-repeat constructs: PUF16wt-2XNRE, PUF16wt-RESTRNA16, 
PUF16rest-s-RESTRNA16. PUF8wt-RESTRNA8 and PUF16wt-RESTRNA16 were considered as 
negative controls, and designed to investigate the structural consequences of not respecting the 
recognition code. To this aim, the PUF proteins were left unaltered, while the RNA molecules were 
mutated to match REST RNA. 
To analyze the simulations, we measured the distances and the non-bonded interaction 
energy between centers of mass (COMs) of RNA nucleotides and facing PUF residues. The COMs 
were defined using the ribonucleotide’s nucleobase and the side chains of the two edge-recognizing 
residues and the residue involved in the stacking interaction. As for the interaction energy 
calculation, electrostatic and van der Waals energy contributions were measured between the same 
groups. Fig. 3.12 reports the results of the distances and energy analysis for the groups that, once 
mutated, showed the most pronounced effect. Specifically, for the 8-repeat systems we show results 
for R7 and the facing 2
nd
 ribonucleotide N2 (Fig. 3.12a-b), while for the 16-repeat systems we 
show results for R4 and the corresponding ribonucleotide N13 (Fig. 3.12c-d). In detail, these 
interaction groups are SE-N with guanosine in PUF8wt-NRE, NQ-Y with uracil in PUF8rest-s-
RESTRNA8, and SE-N with uracil in PUF8wt-RESTRNA8; similarly, they were NQ-H with uracil in 
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PUF16wt-2XNRE, CQ-R with adenine in PUF16rest-s-RESTRNA16, and NQ-H with adenine in 
PUF16wt-RESTRNA16. 
The PUF8wt-RESTRNA8 system (green curve in Fig. 3.12a-b) shows the highest values and 
fluctuations for both distance and energy. Energy values are positive, indicating a destabilizing 
interaction. Between 0 and 50 ns a sudden increase in distance values is observed, which is due to a 
base-flipping event of the ribonucleotide. The corresponding conformation is shown in the snapshot 
at the bottom left of Fig 3.12. It can be observed that the nucleobase points out of the protein-RNA 
interaction surface, away from the corresponding amino acids. Conversely, both PUF8wt-NRE 
(orange curves in Fig. 3.12a-b) and PUF8rest-s-RESTRNA8 (cyan curve) show stable distance 
profiles throughout the simulation at about 5 Å, corresponding to stable non-bonded interaction 
energy values around -30/-20 kcal/mol. For what concerns the 16-repeat constructs, the PUF16wt-
RESTRNA16 system (violet curves in Fig 3.12c-d) shows also high energy and very high distance 
values over the whole simulated trajectory, corresponding again to a base-flipping event. The 
associated conformation is shown in the snapshot at the bottom left of Fig. 3.12, where it can again 
be observed that the nucleobase points away from the protein-RNA interaction surface. PUF16wt-
2XNRE (red curve) and PUF16rest-s-RESTRNA16 (blue curve) show a similar behavior as their 8-
repeat counterparts. In particular, the PUF16rest-s-RESTRNA16 system displays even lower 
distances and energies than the PUF16wt-2XNRE, with plateaus at around 4.5 Å and -20/-30 
kcal/mol, respectively. 
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Figure 3.12 Distance and energy plots for 8-repeat (left) and 16-repeat (right) PUF/RNA systems. On 
the x-axis the simulated time is represented in nanoseconds (ns), while on the y-axis energy and distance are 
reported in kcal/mol and Å, respectively. a. Non-bonded energy plot for the R7-N2 interaction in PUF8wt-
NRE (orange), PUF8wt-RESTRNA8 (green) and PUF8rest-s-RESTRNA8 (cyan). b. Distance between COMs 
of the R7-N2 repeat for PUF8wt-NRE (orange), PUF8wt-RESTRNA8 (green) and PUF8rest-s RESTRNA8 
(cyan). c. Non-bonded energy plot of the R4-N13 interaction in PUF16wt-2XNRE (red), PUF16wt-
RESTRNA16 (violet) and PUF16rest-s-RESTRNA16 (blue). d. Distance between COMs on the R4-N13 
interaction over the PUF16wt-2XNRE (red), PUF16wt-RESTRNA16 (violet) and PUF16rest-s-RESTRNA16 
(blue). Indicated by the colored boxes at the bottom of the figures are snapshots from the simulations 
showing the 3D structures of the flipped bases for PUF8wt-RESTRNA8 (green box) and PUF16wt-
RESTRNA16 (violet box) (images kindly provided by Dr M. Gatti and L. Maragliano, IIT-NSYN, Genova). 
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3.2.7 Eight- and sixteen-repeat PUF proteins mutated in the stacking 
residues selectively tether endogenous REST mRNA without 
altering its expression 
 
Having demonstrated the ability of REST-PUF constructs to bind their specific sequences, 
confirming the selectivity and the affinity of the designed proteins, we decided to investigate 
whether they are able to bind endogenous REST mRNA. To address this point, we performed cross-
linking RNA immunoprecipitation (CLIP) followed by a quantitative analysis with qPCR. N2a cells 
were transfected with PUF8rest-s, PUF16rest-s, PUF8wt and PUF16wt; after 48 h cells were lysed 
and immunoprecipitated with anti-flag antibodies or IgGs as control, and agarose A beads. 
Immunoprecipitated RNA was subsequently analyzed by qRT-PCR with primers specific for REST 
3’UTR and Gapdh as control. Our results indicate that both REST-specific proteins (PUF8rest-s, 
PUF16rest-s) bind endogenous REST mRNA more strongly than their wild type counterparts 
(PUF8wt, PUF16wt). In particular, PUF16rest-s shows a very high binding affinity, as it 
precipitates nine times more REST mRNA than PUF16wt (Fig. 3.13a). We do not detect any 
specific binding of any of the proteins to Gapdh mRNA, confirming the specificity of our results, 
assessed also by the immunoblot of protein fractions (Fig. 3.13b). These data confirm our previous 
results, and establish that eight- and sixteen-repeat PUF proteins mutated in the stacking residues 
specifically bind endogenous REST mRNA. 
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Figure 3.13. Crosslink RNA immunoprecipitation (CLIP) of the REST-PUF stacking constructs for 
endogenous REST mRNA. a. CLIP was performed with agarose A beads, anti-flag and IgGs antibodies on 
N2a cell lysates transfected with the indicated constructs. REST (left panel) and Gapdh (right panel) values 
were normalized against the input value and plotted as percentage of specific precipitation. Data are shown 
as means ± SD of two independent experiments. b. Immunoblot of immunoprecipitated complexes revealed 
with anti-flag antibodies. Input (INP) represents 20% of the cell extract before immunoprecipitation for all 
the indicated constructs. NC, negative control: cells transfected with the empty ‘flag’ vector. 
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PUF proteins mediate the translational regulation of their target mRNAs through various 
mechanisms. We asked whether our PUF constructs have translational repression or activation 
activity when they bind to their target sequence. To answer this question, we cloned the PUF target 
sequences downstream of the Renilla coding sequence before the polyA tail, on a plasmid carrying 
also the luciferase gene (psicheck-2) (Fig. 3.14a) We co-transfected HEK293T cells with PUF8rest-
s, PUF16rest-s, PUF8wt and PUF16wt together with the corresponding target sequences into the 
psicheck-2 vector and performed luciferase assays. We measured the ratio of Renilla over 
Luciferase expression (Fig. 3.14b) and compared it to control samples co-transfected with the 
psichek-2 vector carrying the same target sequence and the flag vector in the absence of PUF 
proteins. We did not observe any change in Renilla expression for all the PUF constructs, 
demonstrating they do not have any intrinsic effect on the translational activity of the target gene. 
Furthermore, we evaluated the effect of PUF constructs on endogenous REST mRNA. We 
transfected N2a cells with PUF8rest-s, PUF16rest-s, PUF8wt and PUF16wt and performed qRT-
PCR analysis to measure REST mRNA levels. As shown in Fig. 3.14c, we did not detect any 
variation in REST mRNA levels, confirming that our PUF constructs do not affect the stability of 
REST mRNA. 
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Figure 3.14. Evaluation of the translational regulation capability of PUF constructs. a. Schematic 
representation of the PUF target sequences, cloned downstream of the Renilla coding sequence, before the 
polyA tail, on the psicheck-2 plasmid. b. Luciferase assay of HEK293T cells co-transfected with the 
indicated constructs and the corresponding target sequences. Luciferase activity was measured 48 h after 
transfection. The Renilla / Luciferase ratio was first calculated for every sample, and data (means ± sem) 
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were subsequently normalized to the activity of the negative control, set to 100 % Renilla (n=3 independent 
experiments). c. N2a cells were transfected with the indicated constructs. After 48 h, REST mRNA levels 
were quantified via qRT-PCR analysis. Gapdh was used as control housekeeping gene. Data (means ± sem) 
of n = 7 independent experiments. 
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4 Discussion 
LOV-based probes to inhibit REST activity. The ability to regulate the activity of transcription 
factors represents an essential step for a better understanding of the molecular and epigenetic 
mechanisms that constitute the basis of cell physiology, and a promising approach in the treatment 
of pathologies linked to dysregulation of specific gene clusters. Epigenetic modifications are crucial 
to rapidly adapt the neuronal transcriptional response to developmental and environmental hints. In 
this context, REST plays a central role in the determination of the neuronal fate [88], as well as in 
the modulation of neuronal activity and plasticity [23]. The role of REST in the onset of pathologies 
is complex, acting under some circumstances as an oncogene and neuroprotector [25], and under 
other conditions as a promoter of insult-induced neuronal death (brain ischemia, HD) [20, 27] or 
dysfunctions like epilepsy [89]. Due to its crucial role in several neuropathologies, various 
molecular strategies have been developed to target REST activity, including decoy 
oligodeoxynucleotides, interfering peptides, and stable expression of dominant-
negative/constitutively active forms of REST [19, 33, 90]. However, all these approaches are 
burdened by intrinsic limitations such as the rapid degradation of the probes or the constitutive and 
non-tunable activation of REST-target genes, which may lead to unwanted side effects. The 
optogenetic tools described here are endowed with several features that circumvent these 
limitations, such as (i) their effect is reversible and can be finely modulated by specific illumination 
protocols; (ii) they can be used for long-term applications, being genetically encoded; and (iii) they 
counteract REST dysregulation without affecting REST expression. In this work, we describe an 
optogenetic approach aimed at modulating gene transcription in a dynamic and reversible way, by 
acting on the activity of the master transcriptional repressor REST. We engineered chimerical 
proteins based on the blue light absorbing AsLOV2 domain and exploited the inhibitory potential of 
small protein domains belonging to the endogenous REST interactors mSin3a and 
RILP/PRICKLE1. Following this strategy, we were able to target two key events in REST 
physiology: (i) the assembly of the repressor complex on RE1 sites and (ii) REST binding to DNA. 
Optogenetic activation of our LOV-based opto-probes selectively induced transcription of REST 
target genes in neuroblastoma cells and in primary neurons. By applying specific illumination 
protocols, we were able to drive and modulate important physiological processes, such as the neural 
differentiation of N2a cells and the firing properties of cortical neurons. These data open the 
possibility to devise novel therapeutic strategies for brain diseases based on the optogenetic control 
of the neuronal epigenome. 
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PUF-based probes: anchors to bind REST mRNA. With the purpose of achieving the bi-
directional control of REST activity we followed a different strategy, based on the direct regulation 
of REST expression acting on its mRNA. In particular we employed PUF domains, a class of RNA 
binding proteins (RBPs) that typically bind to the 3’UTR of mRNA transcripts, acting as post-
transcriptional regulators. The PUF-RNA code has been identified and used in other works to 
engineer PUF proteins endowed with novel sequence specificity. When fused to functional 
domains, the engineered PUF-based proteins were able to modulate the stability of the targeted 
transcripts [71]. Following the published code, we selected a sequence in the 3’UTR of mouse 
REST mRNA that differed in only one base from the wild type PUF target sequence NRE. We 
developed three eight-repeat REST-specific PUFs, one mutated only in the edge-on residues 
(PUF8rest-ns) and the other two mutated in the edge-on and stacking residues (PUF8rest-s and 
PUF8rest-sH). Although the PUF domains are very specific for their targets, a sequence of eight 
ribonucleotides is present at many off target sites in the transcriptome. To overcome this issue, we 
took advantage of a sixteen-repeat PUF domain, which recognizes a 16 bp sequence [62], and 
created three sixteen-repeat REST-specific PUFs, one mutated only in the edge-on residues 
(PUF16rest-ns), one mutated in the edge-on and stacking residues (PUF16rest-s), and another one 
mutated in edge-on and stacking residues, recognizing a different sequence in REST 3’UTR 
(PUF16rest-2.0). All the constructs were correctly expressed in immortalized cell lines (HEK293T, 
N2a), and localized to the cytosol, as expected. Moreover, all the recombinant proteins could be 
purified with similar efficiency, which allow to perform the subsequent analysis of in vitro 
specificity. Our EMSA experiments demonstrated that only the PUF constructs mutated in edge-on 
and stacking residues are able to interact with the selected REST sequence, and not with the NRE 
site. We then determined the binding affinity of PUF8rest-s and PUF16rest-s to their cognate RNA, 
obtaining similar values (Kd 3.8 and 2.6 µM, respectively), which differ from the values obtained 
for the wild type PUF proteins (PUF8wt, 1.3 µM and PUF16wt, 4.1 µM) of 4.9 and 0.6 folds, 
respectively. Thus, the affinity of the mutant proteins for their target RNA is similar but still not as 
good as the one of wild type PUF proteins. This result is in line with the work of Cheong et al [82] 
where the PUF mutants, although specific for their cognate sequences, do not present the same Kd 
values as reported for wild type (for example: mutant7-2(G2U), 6.0 nM, MUT6-2/7-2 (GU23UG), 
18 nM vs wild type, 0.48 nM)[82]. 
These data together with structural modeling and molecular dynamics simulations reveal the 
importance of respecting the recognition code in order to obtain binding between PUF proteins and 
cognate RNA molecules. Indeed, when the code is not maintained, the simulated systems sample 
unstable structures with highly perturbed protein/RNA interaction surfaces. This is reflected in 
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weaker local interactions between the ribonucleotides and the protein residues involved in the 
recognition repeat, which in turn might imply weakly bound complexes. Conversely, when the new 
interfaces for the REST transcript are designed following the recognition code, the simulated 
systems behave locally as the wild-type, or even show an increase in stability as for the PUF16rest-
s-RESTRNA16 system. Although in many works [74, 76, 91] it is proved that by changing only the 
amino acids at positions 12 and 16 PUF reaches the desired specificity, our results, in line with the 
work of Koh YY et al [84], demonstrate that PUF proteins mutated in the residues at positions 12-16 
and 13 are the only mutant proteins that specifically bind REST mRNA, underlying the importance 
to change also the stacking residues in the mutation design since they contribute to the protein 
specificity for RNA sequences, as well as to its affinity. In a recent work Adamala et al [83] 
reported the use of a single repeated module from Pumilio (Pumby) to support protein generation, 
analogous to the TALE design for DNA sequences, with different lengths from 6 to 18 modules, 
whose performances they argue are equivalent to the original Pumilio protein, underlying the fact 
that is possible to engineer PUF proteins specific for any RNA sequence. However these results are 
in contrast with our EMSA results for PUF16rest-2.0, since even if we use the same PUF scaffold, 
changing 9 repeats according to the code (stacking residues included), we are not able to detect any 
specificity. Therefore if on one hand it is fundamental to respect the code in creating new PUF 
constructs, on the other side there are other factors that definitely need to be evaluated in the 
creation of these structures, such as the secondary and tertiary structure of the PUF scaffold that 
determine the correct three-dimensional curvature for RNA binding, ultimately determining binding 
specificity. 
Binding of PUF proteins to their target mRNA could in principle degrade it, stabilize it or 
leave it unaffected [92-94], for this reason we evaluated the affinity of PUF proteins for the 
endogenous REST transcript. In agreement with our in vitro data, our CLIP experiments clearly 
showed that the eight- and sixteen-repeat PUF proteins mutated in the stacking residues bound 
strongly the endogenous REST mRNA. Thus, we provide the first evidence that also the sixteen 
repeat PUF protein can be mutated according to the code in order to specifically bind endogenous 
sequences. Our functional studies demonstrated that PUF8rest-s and PUF16rest-s do not alter the 
translation of a reporter gene, and therefore they do not have any intrinsic effect on REST mRNA 
stability. This is relevant as these constructs will be used as an anchor to target REST mRNA and 
will be fused to effector proteins in order to modulate REST mRNA expression. 
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5 Future Perspectives 
The objective of this thesis was to achieve the bi-directional regulation of the transcriptional 
repressor REST. For what concerns the LOV-based optogenetic strategy, our next step will be to 
test the efficacy of our probes in vivo. In particular, we are interested in using such tools to 
investigate the role of REST a number of plasticity phenomena, such as visual cortex plasticity in 
adult animals. Moreover, we also want to employ these tools to address the role of REST in 
pharmacological and genetic mouse models of epilepsy, in which the function of REST is still 
debated. 
 The described PUF-based probes, instead, will serve as a platform to anchor specific effector 
proteins to REST mRNA. As first strategy we will fuse our constructs to GLD-2, a member of the 
PAP family of PolyA Polymerases that add adenines to the polyA tail of mRNA transcripts, making 
them more stable [95-97]. The PUF-GLD2 fusion proteins should therefore increase REST mRNA 
stability, thus increasing the rate of protein translation. As a final step we will make our probes 
light-sensitive by fusing them to appropriate light-sensitive domains. In this regard, we have 
envisaged two possible strategies. In the first approach we will fuse the LOV domain directly to the 
PUF-GLD-2 chimera. In the resulting construct, illumination should expose the RNA binding site 
allowing PUF to bind REST mRNA, and allowing GLD-2 to add adenines to the polyA tail, 
increasing REST mRNA stability and consequently its translation rate. In the dark state instead the 
Jα helix would mask the RNA recognition site of PUF preventing the binding of PUF to REST 
mRNA and blocking the action of GLD-2 (Fig. 5.1). To identify the best way to link the various 
components of the chimera to each other (i.e. by varying the length and / or the sequence of the 
linker regions), we will perform molecular modeling simulations based on the known crystal 
structure of PUF alone and of the PUF-GLD2 chimera (in collaboration with Drs. L. Maragliano 
and M. Gatti, IIT-NSYN, Genova). As a second strategy we will plan to use the CRY2/CIB 
cryptochrome system, described in par 1.2, fusing CRY2 to PUF and CIB to GLD-2. The light-
induced dimerization of the two fusion proteins would anchor GLD2 to REST mRNA thus allowing 
its action, ultimately stabilizing REST mRNA. 
 Altogether, the approaches here described will allow us to control REST activity bi-
directionally and on-demand, and will therefore represent a powerful tool to interrogate the function 
of this important transcription factor in health and disease. 
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Figure 5.1. a. Schematic representation of the ASLOV2-PUF-GLD-2 chimera. PUF is fused to GLD-2, 
which adds adenines to the polyA, stabilizing the target mRNA. The fusion of this complex to AsLOV2 
makes it light-inducible. In the dark (left) the Jα helix of AsLOV2 masks the PUF RNA recognition site for 
REST mRNA. Upon illumination (right), a change in the Jα conformation allows the binding of PUF on 
REST 3’UTR region and the action of GLD-2, thus increasing REST mRNA stability.  
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Appendix 
Article published by Stefania Criscuolo during the PhD course 
Regulation of neural gene transcription by optogenetic inhibition of the RE1-silencing 
transcription factor.  
Paonessa F, Criscuolo S, Sacchetti S, Amoroso D, Scarongella H, Pecoraro Bisogni F, Carminati 
E, Pruzzo G, Maragliano L, Cesca F, Benfenati F, PNAS 2016 
Abstract 
Optogenetics provides new ways to activate gene transcription; however, no attempts have been 
made as yet to modulate mammalian transcription factors. We report the light-mediated regulation 
of the repressor element 1 (RE1)-silencing transcription factor (REST), a master regulator of neural 
genes. To tune REST activity, we selected two protein domains that impair REST-DNA binding or 
recruitment of the cofactor mSin3a. Computational modeling guided the fusion of the inhibitory 
domains to the light-sensitive Avena sativa light-oxygen-voltage-sensing (LOV) 2-phototrophin 1 
(AsLOV2). By expressing AsLOV2 chimeras in Neuro2a cells, we achieved light-dependent 
modulation of REST target genes that was associated with an improved neural differentiation. In 
primary neurons, light-mediated REST inhibition increased Na(+)-channel 1.2 and brain-derived 
neurotrophic factor transcription and boosted Na(+) currents and neuronal firing. This optogenetic 
approach allows the coordinated expression of a cluster of genes impinging on neuronal activity, 
providing a tool for studying neuronal physiology and correcting gene expression changes taking 
place in brain diseases. 
 
